token|speaker|ts|endTs|punctuation|case|tags
Ladies|UU|1.36|1.72|||
and|UU|1.72|1.81|||
gentlemen|UU|1.81|2.38|,||
thank|UU|2.38|2.62|||
you|UU|2.62|2.71|||
for|UU|2.71|2.86|||
standing|UU|2.86|3.28|||
by|UU|3.28|3.78|||
and|UU|3.97|4.24|||
welcome|UU|4.24|4.57|||
to|UU|4.57|4.69|||
the|UU|4.69|4.81|||
Outhere|UU|4.81|5.29|||
Therapeutic|UU|5.44|6.1|||
second|UU|6.1|6.43|||
quarter|UU|6.43|6.79|.||
Twenty|UU|6.79|7.12|||
twenty|UU|7.12|7.42|||
financial|UU|7.42|7.9|||
results|UU|7.9|8.29|||
conference|UU|8.29|8.74|||
call|UU|8.74|9.13|.||
At|UU|9.55|9.85|||
this|UU|9.85|10.06|||
time|UU|10.06|10.39|,||
all|UU|10.39|10.57|||
participants|UU|10.57|11.2|||
are|UU|11.2|11.38|||
no|UU|11.38|11.5|||
listen|UU|11.5|11.83|||
only|UU|11.83|12.13|||
mode|UU|12.13|12.52|.||
After|UU|12.97|13.39|||
the|UU|13.39|13.48|||
speaker's|UU|13.48|13.87|||
remarks|UU|13.87|14.29|,||
there|UU|14.29|14.47|||
will|UU|14.47|14.68|||
be|UU|14.68|14.8|||
a|UU|14.8|14.89|||
question|UU|14.89|15.34|||
and|UU|15.34|15.46|||
answer|UU|15.46|15.76|||
session|UU|15.76|16.3|||
to|UU|16.69|16.87|||
ask|UU|16.87|17.17|||
a|UU|17.17|17.23|||
question|UU|17.23|17.62|.||
During|UU|17.62|17.86|||
the|UU|17.86|17.95|||
session|UU|17.95|18.43|,||
you|UU|18.58|18.76|||
will|UU|18.76|18.85|||
need|UU|18.85|19.0|||
to|UU|19.0|19.15|||
press|UU|19.15|19.42|||
star|UU|19.42|19.78|||
one|UU|19.78|20.05|||
on|UU|20.05|20.26|||
your|UU|20.26|20.41|||
telephone|UU|20.41|21.13|.||
If|UU|21.46|21.73|||
you|UU|21.73|21.82|||
would|UU|21.82|21.94|||
like|UU|21.94|22.09|||
to|UU|22.09|22.18|||
withdraw|UU|22.18|22.51|||
your|UU|22.51|22.66|||
question|UU|22.66|23.05|,||
press|UU|23.05|23.29|||
the|UU|23.29|23.38|||
pound|UU|23.38|23.71|||
key|UU|23.71|24.01|.||
Please|UU|24.52|24.85|||
be|UU|24.85|24.97|||
advised|UU|24.97|25.39|||
that|UU|25.39|25.51|||
today's|UU|25.51|25.84|||
conference|UU|25.84|26.26|||
is|UU|26.26|26.53|||
being|UU|26.53|26.77|||
recorded|UU|26.77|27.4|.||
If|UU|27.94|28.18|||
you|UU|28.18|28.27|||
require|UU|28.27|28.66|||
further|UU|28.66|28.96|||
assistance|UU|28.96|29.53|,||
please|UU|29.53|29.83|.||
Press|UU|29.83|30.1|||
Star|UU|30.1|30.4|||
zero|UU|30.4|30.97|.||
I|UU|31.33|31.54|||
would|UU|31.54|31.66|||
not|UU|31.66|31.87|||
like|UU|31.87|32.02|||
to|UU|32.02|32.11|||
introduce|UU|32.11|32.59|||
the|UU|32.59|32.68|||
company's|UU|32.68|33.13|||
chief|UU|33.13|33.37|||
financial|UU|33.37|33.85|||
officer|UU|33.85|34.42|,||
Mr.|UU|34.54|34.84|||
Josh|UU|34.84|35.2|.||
ReEdit|UU|35.2|35.59|.||
Mr.|UU|35.68|36.01|||
Joshua|UU|36.01|36.43|||
reedit|UU|36.43|36.82|.||
Thank|UU|37.0|37.36|||
you|UU|37.36|37.57|.||
You|UU|37.57|37.72|||
may|UU|37.72|37.84|||
begin|UU|37.84|38.35|.||
Thank|UU|40.06|40.42|||
you|UU|40.42|40.63|||
and|UU|40.63|40.75|||
good|UU|40.75|40.9|||
morning|UU|40.9|41.2|,||
everyone|UU|41.2|41.68|.||
On|UU|42.16|42.43|||
the|UU|42.43|42.49|||
call|UU|42.49|42.76|||
with|UU|42.76|42.94|||
me|UU|42.94|43.09|||
are|UU|43.09|43.21|||
Dr.|UU|43.21|43.57|||
Todd|UU|43.57|43.87|||
Brady|UU|43.87|44.38|,||
their|UU|44.57|44.91|||
president|UU|44.95|45.46|||
and|UU|45.46|45.61|||
chief|UU|45.61|45.88|||
executive|UU|45.88|46.42|||
officer|UU|46.42|46.98|,||
and|UU|47.2|47.47|||
David|UU|47.47|47.83|||
McMullen|UU|47.83|48.43|,||
our|UU|48.46|48.64|||
chief|UU|48.64|48.88|||
commercial|UU|48.88|49.39|||
officer|UU|49.39|49.93|.||
Dr.|UU|51.04|51.37|||
Brady|UU|51.37|51.7|,||
we'll|UU|51.7|51.91|||
begin|UU|51.91|52.48|||
with|UU|52.51|52.75|||
an|UU|52.75|52.84|||
overview|UU|52.84|53.23|||
of|UU|53.23|53.35|||
our|UU|53.35|53.44|||
recent|UU|53.44|53.8|||
highlights|UU|53.8|54.28|||
and|UU|54.28|54.43|||
upcoming|UU|54.43|55.0|||
clinical|UU|55.0|55.39|||
milestones|UU|55.39|55.94|.||
I|UU|56.77|57.01|||
will|UU|57.01|57.13|||
discuss|UU|57.13|57.61|||
our|UU|57.61|57.7|||
second|UU|57.7|58.03|||
quarter|UU|58.03|58.33|||
financial|UU|58.33|58.78|||
results|UU|58.78|59.23|||
and|UU|59.59|59.86|||
then|UU|59.86|60.01|||
we'll|UU|60.01|60.16|||
take|UU|60.16|60.37|||
your|UU|60.37|60.46|||
questions|UU|60.46|61.0|.||
Please|UU|62.53|62.86|||
note|UU|62.86|63.13|||
that|UU|63.13|63.28|||
this|UU|63.28|63.49|||
morning's|UU|63.49|63.85|||
conference|UU|63.85|64.24|||
call|UU|64.24|64.51|||
contain|UU|64.51|64.93|||
forward|UU|64.94|65.32|||
looking|UU|65.32|65.59|||
statements|UU|65.59|66.16|||
regarding|UU|66.16|66.58|||
future|UU|66.58|66.97|||
events|UU|66.97|67.42|||
and|UU|67.72|67.99|||
the|UU|67.99|68.08|||
future|UU|68.08|68.44|||
performance|UU|68.44|68.95|||
about|UU|68.95|69.22|||
their|UU|69.22|69.43|||
forward|UU|70.36|70.75|||
looking|UU|70.75|71.05|||
statements|UU|71.05|71.53|||
include|UU|71.53|71.98|||
statements|UU|71.99|72.52|||
regarding|UU|72.52|73.03|||
the|UU|73.03|73.18|||
timing|UU|73.18|73.6|||
of|UU|73.6|73.72|||
planned|UU|73.72|74.11|||
clinical|UU|74.11|74.59|||
trial|UU|74.59|74.89|||
initiation|UU|74.89|75.7|||
out|UU|76.09|76.32|||
there|UU|76.36|76.49|||
as|UU|76.51|76.62|||
possible|UU|76.63|77.23|||
or|UU|77.23|77.44|||
assumed|UU|77.44|78.04|||
future|UU|78.04|78.4|||
results|UU|78.4|78.82|||
of|UU|78.82|78.94|||
operation|UU|78.94|79.69|||
expenses|UU|79.84|80.71|||
and|UU|80.71|80.92|||
financial|UU|80.92|81.37|||
position|UU|81.37|81.97|.||
Business|UU|82.81|83.23|||
strategies|UU|83.23|83.89|||
and|UU|83.89|83.98|||
plan|UU|83.98|84.49|||
research|UU|85.06|85.72|.||
Development|UU|85.72|86.41|||
and|UU|86.41|86.59|||
commercial|UU|86.59|87.07|||
plans|UU|87.07|87.52|||
or|UU|87.52|87.67|||
expectations|UU|87.67|88.54|.||
Trends|UU|89.14|89.83|,||
market|UU|89.92|90.31|||
sizing|UU|90.31|90.91|,||
competitive|UU|90.91|91.51|||
position|UU|91.51|92.14|,||
industry|UU|92.47|93.1|,||
environment|UU|93.1|93.73|||
and|UU|93.85|94.09|||
potential|UU|94.09|94.57|||
growth|UU|94.57|94.87|||
opportunities|UU|94.87|95.62|,||
among|UU|95.74|96.1|||
other|UU|96.1|96.34|||
things|UU|96.34|96.58|.||
These|UU|97.63|97.87|||
statements|UU|97.87|98.38|||
are|UU|98.38|98.47|||
based|UU|98.47|98.8|||
upon|UU|98.8|99.1|||
the|UU|99.1|99.22|||
information|UU|99.22|99.82|||
available|UU|99.82|100.33|||
to|UU|100.33|100.51|||
the|UU|100.51|100.6|||
company|UU|100.6|100.99|||
today|UU|100.99|101.41|.||
As|UU|102.67|103.0|||
a|UU|103.0|103.06|||
result|UU|103.06|103.39|||
of|UU|103.39|103.51|||
the|UU|103.51|103.6|||
covid-19|UU|103.6|104.41|||
pandemic|UU|104.41|105.07|,||
clinical|UU|105.67|106.12|||
site|UU|106.12|106.39|||
availability|UU|106.39|107.23|,||
staffing|UU|107.35|108.04|||
and|UU|108.04|108.22|||
patient|UU|108.22|108.61|||
recruitment|UU|108.61|109.18|||
have|UU|109.33|109.57|||
been|UU|109.6|109.75|||
negatively|UU|109.75|110.38|||
affected|UU|110.38|110.95|||
and|UU|111.13|111.37|||
the|UU|111.37|111.46|||
timeline|UU|111.46|112.03|||
to|UU|112.06|112.24|||
complete|UU|112.24|112.66|||
our|UU|112.66|112.75|||
clinical|UU|112.75|113.17|||
trials|UU|113.17|113.68|||
may|UU|113.71|114.01|||
be|UU|114.01|114.16|||
delayed|UU|114.16|114.64|.||
There|UU|115.87|116.08|||
is|UU|116.08|116.29|||
no|UU|116.5|116.8|||
obligation|UU|116.8|117.43|||
to|UU|117.43|117.55|||
update|UU|117.55|117.97|||
these|UU|117.97|118.12|||
statements|UU|118.12|118.63|||
that|UU|118.63|118.72|||
circumstances|UU|118.72|119.59|||
change|UU|119.59|120.07|.||
Future|UU|121.03|121.45|||
events|UU|121.45|121.9|||
and|UU|122.32|122.62|||
actual|UU|122.62|122.95|||
results|UU|122.95|123.43|||
could|UU|123.52|123.73|||
differ|UU|123.73|124.03|||
materially|UU|124.03|124.78|||
from|UU|124.78|124.99|||
those|UU|124.99|125.23|||
projected|UU|125.23|125.8|||
in|UU|125.8|125.92|||
the|UU|125.92|125.98|||
company's|UU|125.98|126.43|||
forward|UU|126.43|126.7|||
looking|UU|126.7|127.0|||
statements|UU|127.0|127.57|,||
including|UU|127.84|128.39|||
the|UU|128.39|128.5|||
current|UU|128.5|128.92|||
and|UU|129.01|129.25|||
potential|UU|129.25|129.7|||
future|UU|129.7|130.06|||
impact|UU|130.06|130.63|||
of|UU|130.81|131.02|||
the|UU|131.05|131.14|||
covid-19|UU|131.14|131.95|||
pandemic|UU|131.95|132.55|||
on|UU|132.55|132.67|||
our|UU|132.67|132.79|||
business|UU|132.79|133.29|,||
results|UU|133.6|134.05|||
of|UU|134.05|134.17|||
operations|UU|134.17|134.98|||
and|UU|134.98|135.22|||
financial|UU|135.22|135.76|||
position|UU|135.76|136.33|.||
Additional|UU|138.26|138.85|||
information|UU|138.85|139.33|||
concerning|UU|139.33|139.78|||
factors|UU|139.78|140.23|||
that|UU|140.23|140.38|||
could|UU|140.38|140.71|||
cause|UU|140.71|141.07|||
results|UU|141.07|141.52|||
to|UU|141.52|141.64|||
differ|UU|141.64|141.97|||
materially|UU|141.97|142.63|||
from|UU|142.63|142.84|||
our|UU|142.84|142.96|||
forward|UU|142.96|143.23|||
looking|UU|143.23|143.47|||
statements|UU|143.47|144.01|||
are|UU|144.28|144.49|||
described|UU|144.49|145.03|||
in|UU|145.03|145.12|||
greater|UU|145.12|145.45|||
detail|UU|145.45|146.02|,||
and|UU|146.14|146.35|||
the|UU|146.35|146.44|||
company's|UU|146.44|146.89|||
press|UU|146.89|147.19|||
release|UU|147.19|147.58|,||
issued|UU|147.58|147.88|||
this|UU|147.88|148.12|||
morning|UU|148.12|148.54|||
containing|UU|148.66|149.2|||
financial|UU|149.2|149.65|||
results|UU|149.65|150.1|||
for|UU|150.1|150.25|||
the|UU|150.25|150.34|||
quarter|UU|150.34|150.7|,||
ended|UU|150.7|150.97|||
June|UU|150.97|151.33|||
30|UU|151.33|151.72|,||
2020|UU|151.72|152.62|,||
and|UU|153.01|153.25|||
the|UU|153.25|153.34|||
company's|UU|153.34|153.82|||
filings|UU|153.82|154.24|||
with|UU|154.24|154.36|||
the|UU|154.36|154.51|||
FCC|UU|154.51|155.1|.||
And|UU|155.86|156.1|||
with|UU|156.1|156.28|||
that|UU|156.28|156.58|,||
I'll|UU|156.79|157.03|||
turn|UU|157.03|157.3|||
the|UU|157.3|157.36|||
call|UU|157.36|157.66|||
over|UU|157.66|157.87|||
to|UU|157.87|157.99|||
Dr.|UU|157.99|158.35|||
Tom|UU|158.35|158.62|||
Brady|UU|158.62|159.04|,||
our|UU|159.31|159.49|||
president|UU|159.49|160.0|||
and|UU|160.0|160.12|||
chief|UU|160.12|160.39|||
executive|UU|160.39|160.87|||
officer|UU|160.87|161.43|.||
Thank|UU|164.32|164.59|||
you|UU|164.59|164.68|,||
Joshua|UU|164.68|165.16|,||
and|UU|165.17|165.28|||
good|UU|165.28|165.43|||
morning|UU|165.43|165.7|,||
everyone|UU|165.7|166.17|.||
As|UU|167.49|167.91|||
our|UU|167.91|168.24|||
industry|UU|168.24|168.9|||
and|UU|168.9|169.11|||
health|UU|169.11|169.35|||
care|UU|169.35|169.62|||
first|UU|169.62|170.01|||
responders|UU|170.01|170.82|||
continue|UU|170.82|171.24|||
working|UU|171.24|171.6|||
together|UU|171.6|172.05|||
to|UU|172.05|172.65|||
defeat|UU|172.65|173.16|||
the|UU|173.16|173.31|||
worst|UU|173.31|173.7|||
public|UU|173.7|174.12|||
health|UU|174.12|174.36|||
crisis|UU|174.36|174.9|||
in|UU|174.9|174.99|||
a|UU|174.99|175.05|||
century|UU|175.05|175.67|,||
our|UU|176.28|176.7|||
thoughts|UU|176.7|177.24|||
are|UU|177.24|177.48|||
with|UU|177.48|177.75|||
those|UU|177.75|178.17|||
affected|UU|178.17|178.74|||
by|UU|178.74|179.1|||
covid-19|UU|179.1|180.12|.||
The|UU|181.08|181.41|||
seemingly|UU|181.41|182.04|||
relentless|UU|182.04|182.58|||
spread|UU|182.58|183.0|||
of|UU|183.0|183.09|||
the|UU|183.09|183.18|||
novel|UU|183.18|183.54|||
coronavirus|UU|183.54|184.38|||
has|UU|184.38|184.59|||
made|UU|184.59|184.86|||
20|UU|184.86|185.25|||
20|UU|185.25|185.76|||
a|UU|185.76|186.02|||
tragic|UU|186.03|186.72|||
and|UU|186.72|187.08|||
surreal|UU|187.08|187.8|||
year|UU|187.8|188.28|.||
But|UU|188.97|189.21|||
we|UU|189.24|189.39|||
remain|UU|189.39|189.84|||
hopeful|UU|189.84|190.5|||
and|UU|190.5|190.74|||
confident|UU|190.74|191.46|||
in|UU|191.46|191.55|||
the|UU|191.55|191.67|||
abilities|UU|191.67|192.42|||
of|UU|192.42|192.69|||
our|UU|192.69|192.87|||
industry|UU|192.87|193.41|||
to|UU|193.41|193.71|||
develop|UU|193.71|194.13|||
the|UU|194.13|194.22|||
therapies|UU|194.22|194.79|||
necessary|UU|194.79|195.6|||
to|UU|196.05|196.23|||
extinguish|UU|196.23|197.04|||
this|UU|197.04|197.34|||
virulent|UU|197.34|197.91|||
disease|UU|197.91|198.54|.||
I|UU|199.59|199.83|||
again|UU|199.83|200.22|||
want|UU|200.22|200.49|||
to|UU|200.49|200.76|||
especially|UU|200.76|201.42|||
thank|UU|201.42|201.93|||
our|UU|201.93|202.29|||
team|UU|202.29|202.86|||
for|UU|203.31|203.55|||
their|UU|203.55|203.79|||
work|UU|203.79|204.21|||
and|UU|204.21|204.33|||
dedication|UU|204.33|205.02|||
to|UU|205.02|205.2|||
our|UU|205.2|205.32|||
mission|UU|205.32|205.91|,||
developing|UU|205.92|206.64|||
first|UU|206.64|207.03|||
in|UU|207.03|207.15|||
class|UU|207.15|207.54|||
medicines|UU|207.54|208.2|||
to|UU|208.2|208.35|||
improve|UU|208.35|208.86|||
the|UU|208.86|208.98|||
lives|UU|208.98|209.49|||
of|UU|209.49|209.58|||
patients|UU|209.58|210.12|||
with|UU|210.12|210.3|||
immunological|UU|210.3|210.96|||
diseases|UU|210.96|211.59|||
whose|UU|211.59|211.8|||
conditions|UU|211.8|212.46|||
are|UU|213.06|213.3|||
not|UU|213.3|213.54|||
being|UU|213.54|213.81|||
adequately|UU|213.81|214.35|||
treated|UU|214.35|214.77|||
by|UU|214.77|214.95|||
the|UU|214.95|215.04|||
current|UU|215.04|215.49|||
standard|UU|215.94|216.39|||
of|UU|216.39|216.48|||
care|UU|216.48|216.86|.||
From|UU|219.39|219.66|||
our|UU|219.66|219.78|||
perspective|UU|219.78|220.47|,||
the|UU|220.5|220.68|||
key|UU|220.68|220.98|||
pipeline|UU|220.98|221.55|||
development|UU|221.55|222.1|||
to|UU|222.1|222.18|||
the|UU|222.2|222.3|||
second|UU|222.3|222.66|||
quarter|UU|222.66|223.11|||
was|UU|223.11|223.47|||
our|UU|223.47|223.8|||
type|UU|223.8|224.13|||
C|UU|224.13|224.37|||
meeting|UU|224.37|224.7|||
with|UU|224.7|224.88|||
the|UU|224.88|224.97|||
FDA|UU|224.97|225.69|,||
which|UU|226.35|226.83|||
charted|UU|226.83|227.28|||
the|UU|227.28|227.37|||
remaining|UU|227.37|227.88|||
clinical|UU|227.88|228.3|||
pathway|UU|228.3|228.9|||
to|UU|228.9|229.08|||
an|UU|229.08|229.17|||
NDA|UU|229.17|229.59|||
submission|UU|229.59|230.28|||
for|UU|230.82|231.03|||
topical|UU|231.03|231.54|||
ocular|UU|231.54|231.98|||
caprock|UU|231.98|232.33|||
collapse|UU|232.36|232.88|||
and|UU|233.19|233.46|||
dry|UU|233.46|233.79|||
eye|UU|233.79|233.94|||
disease|UU|233.94|234.54|.||
The|UU|235.5|235.68|||
meeting|UU|235.68|236.16|||
culminated|UU|236.16|236.97|||
in|UU|237.48|237.72|||
an|UU|237.72|237.81|||
agreement|UU|237.81|238.26|||
to|UU|238.26|238.38|||
use|UU|238.38|238.65|||
levels|UU|238.65|239.1|||
of|UU|239.1|239.31|||
reactive|UU|239.31|239.76|||
aldehyde|UU|239.76|240.21|||
species|UU|240.21|240.84|||
or|UU|240.84|241.02|||
RASSMAN|UU|241.02|241.55|,||
the|UU|241.98|242.13|||
therapeutic|UU|242.13|242.73|||
target|UU|242.73|243.12|||
for|UU|243.12|243.3|||
approx|UU|243.3|243.7|||
OLAP|UU|243.72|244.08|||
as|UU|244.53|244.76|||
an|UU|244.79|244.89|||
objective|UU|244.89|245.34|||
sign|UU|245.34|245.73|||
endpoint|UU|245.73|246.21|||
for|UU|246.21|246.39|||
subsequent|UU|246.39|247.11|||
clinical|UU|247.11|247.77|||
evaluation|UU|247.77|248.61|.||
In|UU|250.62|250.83|||
the|UU|250.83|250.89|||
fourth|UU|250.89|251.16|||
quarter|UU|251.16|251.43|||
of|UU|251.43|251.52|||
this|UU|251.52|251.73|||
year|UU|251.73|252.06|,||
we|UU|252.34|252.57|||
plan|UU|252.57|252.87|||
to|UU|252.87|252.99|||
initiate|UU|252.99|253.41|||
clinical|UU|253.41|253.8|||
testing|UU|253.8|254.25|||
to|UU|254.25|254.43|||
assess|UU|254.43|254.91|||
the|UU|254.91|255.06|||
activity|UU|255.06|255.57|||
of|UU|255.57|255.66|||
topical|UU|255.66|256.05|||
ocular|UU|256.05|256.42|||
approx|UU|256.42|256.8|||
OLAP|UU|256.8|257.1|||
in|UU|257.13|257.25|||
reducing|UU|257.25|257.79|||
teir|UU|257.79|258.09|||
levels|UU|258.09|258.48|||
of|UU|258.48|258.63|||
rasped|UU|258.63|259.11|||
and|UU|259.56|259.83|||
other|UU|259.83|260.13|||
objective|UU|260.13|260.58|||
signs|UU|260.58|261.11|||
of|UU|261.12|261.24|||
dry|UU|261.24|261.54|||
eye|UU|261.54|261.69|||
disease|UU|261.69|262.29|.||
And|UU|262.71|262.98|||
we|UU|262.98|263.1|||
expect|UU|263.1|263.52|||
preliminary|UU|263.52|264.09|||
results|UU|264.09|264.6|||
by|UU|264.6|264.78|||
the|UU|264.78|264.93|||
end|UU|264.93|265.05|||
of|UU|265.05|265.11|||
the|UU|265.11|265.2|||
year|UU|265.2|265.53|.||
The|UU|266.7|266.85|||
timing|UU|266.85|267.42|||
of|UU|267.42|267.63|||
the|UU|267.72|267.81|||
clinical|UU|267.81|268.17|||
trial|UU|268.17|268.56|||
is|UU|268.56|268.77|,||
of|UU|268.77|268.86|||
course|UU|268.86|269.22|,||
subject|UU|269.22|269.64|||
to|UU|269.64|269.73|||
finalisation|UU|269.73|270.54|||
of|UU|270.54|270.63|||
trial|UU|270.63|270.93|||
design|UU|270.93|271.59|,||
ratha|UU|271.95|272.48|||
assay|UU|272.49|272.91|||
development|UU|272.91|273.57|||
and|UU|273.57|273.78|||
potential|UU|273.78|274.26|||
disruptions|UU|274.26|275.13|||
due|UU|275.61|275.94|||
to|UU|275.94|276.09|||
covid-19|UU|276.09|277.11|.||
Initiation|UU|278.38|279.07|||
of|UU|279.07|279.16|||
a|UU|279.16|279.22|||
safety|UU|279.22|279.76|||
study|UU|279.76|280.24|||
and|UU|280.24|280.45|||
dry|UU|280.45|280.72|||
eye|UU|280.72|280.78|||
disease|UU|280.78|281.23|||
patients|UU|281.23|281.77|||
is|UU|281.77|281.95|||
also|UU|281.95|282.31|||
planned|UU|282.31|282.76|||
for|UU|282.76|282.88|||
the|UU|282.88|282.97|||
fourth|UU|282.97|283.27|||
quarter|UU|283.27|283.69|||
and|UU|284.2|284.5|||
NDA|UU|284.5|284.89|||
submission|UU|284.89|285.46|||
is|UU|285.46|285.61|||
expected|UU|285.61|286.24|||
by|UU|286.6|286.84|||
the|UU|286.84|286.99|||
end|UU|286.99|287.23|||
of|UU|287.23|287.35|||
twenty|UU|287.35|287.8|||
twenty|UU|287.8|288.16|||
one|UU|288.16|288.46|.||
Our|UU|290.76|291.12|||
optimism|UU|291.12|291.72|||
for|UU|291.72|291.87|||
the|UU|291.87|291.96|||
use|UU|291.96|292.2|||
of|UU|292.2|292.35|||
race|UU|292.35|292.77|||
as|UU|292.84|293.01|||
an|UU|293.01|293.1|||
objective|UU|293.1|293.58|||
sign|UU|293.58|293.97|||
of|UU|293.97|294.06|||
dry|UU|294.07|294.39|||
disease|UU|294.39|294.96|||
is|UU|294.96|295.11|||
supported|UU|295.11|295.71|||
by|UU|295.71|295.98|||
data|UU|295.98|296.4|||
from|UU|296.4|296.64|||
our|UU|296.64|296.76|||
successful|UU|296.76|297.57|||
phase|UU|297.57|298.05|||
to|UU|298.05|298.39|||
a|UU|298.39|298.62|||
trial|UU|298.65|299.22|||
in|UU|299.91|300.18|||
which|UU|300.18|300.39|||
Scilab|UU|300.78|301.15|||
treatment|UU|301.17|301.59|||
diminished|UU|301.59|302.07|||
levels|UU|302.07|302.55|||
of|UU|302.55|302.7|||
raspier|UU|302.71|303.9|,||
rather|UU|303.9|304.32|,||
and|UU|304.41|304.53|||
tears|UU|304.53|305.1|||
as|UU|305.28|305.64|||
measured|UU|305.64|306.03|||
by|UU|306.03|306.21|||
Alysa|UU|306.21|306.77|||
following|UU|306.78|307.35|||
twenty|UU|307.35|307.65|||
eight|UU|307.65|307.8|||
days|UU|307.8|308.25|||
of|UU|308.43|308.56|||
treatment|UU|308.64|309.09|||
for|UU|309.9|310.08|||
the|UU|310.08|310.17|||
upcoming|UU|310.17|310.53|||
rasped|UU|310.53|310.83|||
trials|UU|310.86|311.43|.||
The|UU|311.7|311.85|||
longest|UU|311.85|312.27|||
duration|UU|312.27|312.9|||
dosing|UU|312.96|313.44|||
under|UU|313.44|313.65|||
consideration|UU|313.65|314.4|||
is|UU|314.4|314.52|||
also|UU|314.52|314.85|||
twenty|UU|314.85|315.15|||
eight|UU|315.15|315.27|||
days|UU|315.27|315.75|,||
whereas|UU|315.75|316.2|||
the|UU|316.2|316.35|||
shortest|UU|316.35|316.86|||
dosing|UU|316.86|317.25|||
duration|UU|317.25|317.82|||
is|UU|318.57|318.93|||
one|UU|318.93|319.29|||
to|UU|319.29|319.47|||
two|UU|319.47|319.71|||
days|UU|319.71|320.16|.||
Additionally|UU|321.03|321.84|,||
the|UU|321.84|321.96|||
upcoming|UU|321.96|322.38|||
trials|UU|322.68|323.16|||
will|UU|323.16|323.31|||
include|UU|323.31|323.76|||
a|UU|323.76|323.82|||
chamber|UU|323.82|324.27|||
assessment|UU|324.27|324.81|||
to|UU|324.81|324.93|||
measure|UU|324.93|325.23|||
the|UU|325.23|325.35|||
effect|UU|325.35|325.74|||
of|UU|325.74|325.86|||
acute|UU|325.86|326.22|||
changes|UU|326.22|326.73|||
in|UU|326.73|326.88|||
dryness|UU|326.88|327.69|||
on|UU|327.69|327.93|||
rats|UU|327.93|328.38|||
and|UU|329.1|329.58|||
other|UU|329.58|329.85|||
signs|UU|329.85|330.36|||
and|UU|330.36|330.48|||
symptoms|UU|330.48|331.17|||
of|UU|331.56|331.8|||
dry|UU|331.8|332.07|||
eye|UU|332.07|332.22|||
disease|UU|332.22|332.8|.||
We'll|UU|334.08|334.32|||
be|UU|334.32|334.44|||
sharing|UU|334.44|334.83|||
additional|UU|334.83|335.37|||
details|UU|335.37|335.94|||
of|UU|335.94|336.0|||
the|UU|336.0|336.09|||
protocol|UU|336.09|336.81|||
following|UU|336.81|337.41|||
assay|UU|337.89|338.34|||
validation|UU|338.34|339.18|||
and|UU|339.18|339.42|||
FDA|UU|339.42|339.81|||
requirement|UU|339.81|340.47|||
and|UU|340.95|341.25|||
look|UU|341.25|341.43|||
forward|UU|341.43|341.73|||
to|UU|341.73|341.85|||
providing|UU|341.85|342.3|||
trial|UU|342.3|342.66|||
design|UU|342.66|343.23|||
shortly|UU|343.35|343.89|.||
From|UU|345.09|345.39|||
a|UU|345.39|345.45|||
safety|UU|345.45|345.9|||
perspective|UU|345.9|346.65|,||
topical|UU|346.65|347.13|||
ocular|UU|347.13|347.55|||
approx|UU|347.55|348.0|.||
Lappe|UU|348.0|348.36|||
already|UU|348.36|349.02|||
has|UU|349.02|349.26|||
been|UU|349.26|349.41|||
evaluated|UU|349.41|350.19|||
in|UU|350.19|350.37|||
more|UU|350.37|350.61|||
than|UU|350.61|350.82|||
1000|UU|350.82|351.78|||
patients|UU|351.78|352.41|||
with|UU|352.95|353.25|||
no|UU|353.25|353.91|||
observed|UU|353.91|354.6|||
safety|UU|354.84|355.29|||
concerns|UU|355.29|355.93|.||
In|UU|356.67|356.86|||
short|UU|357.09|357.54|,||
the|UU|357.72|357.87|||
safety|UU|357.87|358.41|,||
consistency|UU|358.41|359.31|||
and|UU|359.31|359.46|||
clinically|UU|359.46|360.06|||
significant|UU|360.06|360.6|||
activity|UU|360.6|361.05|||
of|UU|361.05|361.14|||
approx|UU|361.14|361.62|||
OLAP|UU|361.62|361.98|||
across|UU|362.31|362.85|||
numerous|UU|362.85|363.36|||
clinical|UU|363.36|363.72|||
trials|UU|363.72|364.26|||
suggests|UU|365.01|365.46|||
that|UU|365.46|365.58|||
reproachful|UU|365.58|366.12|||
could|UU|366.27|366.48|||
be|UU|366.48|366.66|||
an|UU|366.66|366.75|||
important|UU|366.75|367.35|||
addition|UU|367.35|367.92|||
to|UU|367.92|368.07|||
the|UU|368.07|368.19|||
limited|UU|368.19|368.73|||
number|UU|368.73|369.12|||
of|UU|369.12|369.24|||
therapeutic|UU|369.24|369.93|||
options|UU|369.93|370.38|||
for|UU|370.38|370.53|||
dry|UU|370.53|370.81|||
eye|UU|370.81|370.92|||
disease|UU|370.92|371.49|,||
which|UU|372.03|372.3|||
affects|UU|372.3|372.72|||
more|UU|372.72|372.9|||
than|UU|372.9|373.11|||
30|UU|373.11|373.71|||
million|UU|373.71|374.16|||
patients|UU|374.16|374.82|||
in|UU|375.18|375.42|||
the|UU|375.42|375.48|||
United|UU|375.48|375.81|||
States|UU|375.81|376.32|.||
Looking|UU|378.03|378.36|||
at|UU|378.36|378.45|||
other|UU|378.45|378.69|||
ocular|UU|378.69|379.08|||
programs|UU|379.08|379.59|||
in|UU|379.59|379.68|||
our|UU|379.68|379.8|||
pipeline|UU|379.8|380.49|,||
topline|UU|380.49|381.06|||
results|UU|381.06|381.57|||
from|UU|381.57|381.75|||
the|UU|381.75|381.87|||
Phase|UU|381.87|382.44|||
three|UU|382.44|382.98|||
invigorate|UU|382.98|383.73|||
Allergan|UU|383.73|384.36|||
Chamber|UU|384.36|384.81|||
trial|UU|384.81|385.23|||
of|UU|385.23|385.38|||
approx|UU|385.38|385.83|||
Laffan|UU|385.83|386.19|||
allergic|UU|386.19|386.55|||
conjunctivitis|UU|386.55|387.42|||
are|UU|387.93|388.2|||
expected|UU|388.2|388.8|||
in|UU|388.8|388.92|||
the|UU|388.92|388.98|||
first|UU|388.98|389.34|||
half|UU|389.34|389.67|||
of|UU|389.67|389.88|||
twenty|UU|390.27|390.75|||
twenty|UU|390.75|391.14|||
one|UU|391.14|391.56|||
and|UU|393.3|393.51|||
the|UU|393.51|393.6|||
retinal|UU|393.6|393.9|||
disease|UU|393.9|394.29|||
area|UU|394.29|394.61|||
in|UU|394.62|394.68|||
the|UU|394.68|394.77|||
second|UU|394.77|395.07|||
quarter|UU|395.07|395.4|||
of|UU|395.4|395.49|||
this|UU|395.49|395.73|||
year|UU|395.73|396.06|,||
the|UU|396.06|396.21|||
European|UU|396.21|396.87|||
Commission|UU|396.87|397.32|||
granted|UU|397.32|397.77|||
orphan|UU|397.8|398.22|||
medicinal|UU|398.22|398.73|||
product|UU|398.73|399.12|||
designation|UU|399.12|399.87|||
to|UU|400.26|400.47|||
ATX|UU|400.47|400.82|||
twenty|UU|400.92|401.25|||
one|UU|401.25|401.43|||
ninety|UU|401.43|401.73|||
one|UU|401.73|402.06|||
for|UU|402.66|402.84|||
the|UU|402.84|402.9|||
treatment|UU|402.9|403.29|||
of|UU|403.29|403.38|||
retinal|UU|403.38|403.71|||
detachment|UU|403.71|404.37|.||
Opening|UU|404.82|405.27|||
a|UU|405.27|405.36|||
new|UU|405.36|405.57|||
market|UU|405.57|405.99|||
opportunity|UU|405.99|406.59|||
for|UU|406.59|406.77|||
ATX|UU|406.77|407.16|||
twenty|UU|407.16|407.46|||
one|UU|407.46|407.61|||
ninety|UU|407.61|407.88|||
one|UU|407.88|408.09|||
in|UU|408.09|408.18|||
the|UU|408.18|408.27|||
European|UU|408.27|408.78|||
Union|UU|408.78|409.2|||
is|UU|409.2|409.35|||
drugs|UU|409.35|409.74|.||
Receiving|UU|409.74|410.43|||
the|UU|410.43|410.58|||
orphan|UU|410.58|410.94|||
medicinal|UU|410.94|411.33|||
product|UU|411.33|411.66|||
designation|UU|411.66|412.35|||
are|UU|412.83|413.04|||
eligible|UU|413.04|413.65|||
for|UU|413.65|413.71|||
the|UU|413.71|413.79|||
protocol|UU|413.79|414.3|||
assistance|UU|414.3|415.05|,||
research|UU|415.05|415.59|||
funding|UU|415.59|416.1|||
and|UU|416.37|416.85|||
upon|UU|416.85|417.12|||
approval|UU|417.12|417.72|.||
Ten|UU|417.72|418.02|||
years|UU|418.05|418.56|||
of|UU|418.56|418.86|||
EU|UU|418.86|419.49|||
market|UU|419.52|420.12|||
exclusivity|UU|420.12|420.96|.||
ADX|UU|422.61|423.13|||
twenty|UU|423.15|423.42|||
one|UU|423.42|423.72|||
twenty|UU|424.05|424.41|||
one|UU|424.41|424.56|||
ninety|UU|424.56|424.83|||
one|UU|424.83|425.07|.||
Our|UU|425.07|425.25|||
novel|UU|425.25|425.7|||
and|UU|425.7|425.79|||
proprietary|UU|425.79|426.54|||
interventional|UU|426.54|427.17|||
methotrexate|UU|427.17|427.89|||
induction|UU|427.89|428.49|||
is|UU|428.76|429.03|||
being|UU|429.03|429.3|||
evaluated|UU|429.3|429.96|||
in|UU|429.96|430.05|||
the|UU|430.05|430.14|||
Phase|UU|430.14|430.59|||
three|UU|430.59|431.07|||
guard|UU|431.07|431.52|||
trial|UU|431.52|432.06|||
for|UU|432.06|432.33|||
proliferative|UU|432.33|433.05|||
Vibrio|UU|433.08|433.43|||
retinopathy|UU|433.53|434.31|.||
TVR|UU|435.33|435.93|||
is|UU|435.93|436.08|||
a|UU|436.08|436.2|||
rare|UU|436.2|436.83|||
blood|UU|436.86|437.19|||
site|UU|437.19|437.55|||
threatening|UU|437.55|438.12|||
condition|UU|438.12|438.72|||
and|UU|438.93|439.34|||
a|UU|439.35|439.41|||
leading|UU|439.41|439.74|||
cause|UU|439.74|440.07|||
of|UU|440.07|440.13|||
failure|UU|440.14|440.64|||
of|UU|440.64|440.73|||
retinal|UU|440.73|441.0|||
detachment|UU|441.0|441.54|||
surgery|UU|441.54|442.17|||
affecting|UU|442.59|443.19|||
roughly|UU|443.19|443.55|||
4000|UU|443.55|444.3|||
patients|UU|444.3|444.78|||
per|UU|444.78|445.17|||
year|UU|445.17|445.56|||
in|UU|445.56|445.65|||
the|UU|445.65|445.74|||
United|UU|445.74|446.1|||
States|UU|446.1|446.61|,||
nearly|UU|447.2|447.57|||
twice|UU|447.57|447.96|||
as|UU|447.96|448.14|||
many|UU|448.14|448.41|||
in|UU|448.41|448.56|||
Europe|UU|448.56|449.04|||
and|UU|449.04|449.25|||
Japan|UU|449.25|449.82|||
combined|UU|449.82|450.48|.||
Given|UU|451.5|451.8|||
the|UU|451.8|451.86|||
nature|UU|451.86|452.22|||
of|UU|452.22|452.31|||
PBR|UU|452.31|453.09|||
and|UU|453.09|453.45|||
given|UU|453.45|453.78|||
the|UU|453.78|453.84|||
clinical|UU|453.84|454.23|||
site|UU|454.23|454.56|||
delays|UU|454.56|455.04|||
caused|UU|455.04|455.4|||
by|UU|455.4|455.61|||
covid-19|UU|455.61|456.66|,||
the|UU|457.05|457.23|||
progress|UU|457.23|457.77|||
of|UU|457.77|457.95|||
guard|UU|457.95|458.43|||
has|UU|458.43|458.7|||
been|UU|458.7|458.97|||
slow|UU|458.97|459.69|.||
Although|UU|460.05|460.65|||
we|UU|460.65|460.86|||
expect|UU|460.86|461.31|||
to|UU|461.31|461.43|||
provide|UU|461.43|461.85|||
you|UU|461.85|461.97|||
with|UU|461.97|462.09|||
an|UU|462.09|462.21|||
update|UU|462.21|462.69|||
by|UU|462.87|463.11|||
the|UU|463.11|463.26|||
end|UU|463.26|463.35|||
of|UU|463.35|463.41|||
this|UU|463.41|463.59|||
year|UU|463.59|463.92|.||
As|UU|465.24|465.48|||
many|UU|465.48|465.69|||
of|UU|465.69|465.78|||
you|UU|465.78|465.9|||
know|UU|465.9|466.23|,||
there|UU|466.23|466.44|||
is|UU|466.44|466.62|||
no|UU|466.62|467.13|||
approved|UU|467.13|467.58|||
therapy|UU|467.58|468.12|||
for|UU|468.24|468.45|||
PVR|UU|468.45|469.08|||
and|UU|469.62|469.89|||
ATX|UU|469.89|470.26|.||
Twenty|UU|470.28|470.58|||
one|UU|470.58|470.76|||
ninety|UU|470.76|471.03|||
one|UU|471.03|471.24|||
has|UU|471.24|471.45|||
received|UU|471.45|471.96|||
orphan|UU|471.96|472.32|||
drug|UU|472.32|472.71|||
and|UU|472.71|472.89|||
fast|UU|472.89|473.22|||
track|UU|473.22|473.52|||
designations|UU|473.52|474.33|||
from|UU|474.9|475.17|||
the|UU|475.17|475.26|||
FDA|UU|475.26|475.77|.||
ADX|UU|477.88|478.25|||
twenty|UU|478.39|478.63|||
one|UU|478.63|478.78|||
ninety|UU|478.78|479.05|||
one|UU|479.05|479.2|||
is|UU|479.2|479.35|||
also|UU|479.35|479.77|||
the|UU|479.77|479.86|||
subject|UU|479.86|480.34|||
of|UU|480.34|480.46|||
our|UU|480.46|480.61|||
new|UU|480.61|480.85|||
clinical|UU|480.85|481.3|||
program|UU|481.3|481.96|||
and|UU|481.96|482.11|||
primary|UU|482.11|482.8|||
victory|UU|482.8|483.13|||
of|UU|483.13|483.22|||
retinol|UU|483.22|483.79|||
lymphoma|UU|484.0|484.84|||
for|UU|484.91|485.2|||
PRL|UU|485.2|486.22|,||
a|UU|486.55|486.79|||
rare|UU|486.79|487.3|,||
aggressive|UU|487.3|487.96|||
high|UU|487.96|488.2|||
grade|UU|488.2|488.53|||
cancer|UU|488.53|489.07|||
that|UU|489.07|489.22|||
affects|UU|489.22|489.67|||
approximately|UU|489.67|490.51|||
twenty|UU|490.51|490.81|||
nine|UU|490.81|490.99|||
hundred|UU|490.99|491.35|||
people|UU|491.35|491.77|||
in|UU|491.77|491.86|||
the|UU|491.86|491.92|||
United|UU|491.92|492.25|||
States|UU|492.25|492.73|,||
with|UU|493.48|493.69|||
about|UU|493.69|493.93|||
six|UU|493.93|494.23|||
hundred|UU|494.23|494.53|||
new|UU|494.53|494.74|||
cases|UU|494.74|495.28|||
diagnosed|UU|495.28|496.03|||
annually|UU|496.03|496.63|.||
There|UU|497.53|497.8|||
are|UU|497.83|498.07|||
no|UU|498.07|498.43|||
approved|UU|498.43|498.85|||
treatments|UU|498.85|499.33|||
for|UU|499.33|499.45|||
the|UU|499.45|499.54|||
disease|UU|499.54|500.08|,||
although|UU|500.08|500.47|||
the|UU|500.47|500.59|||
standard|UU|500.59|501.01|||
of|UU|501.01|501.13|||
care|UU|501.13|501.64|||
is|UU|501.64|501.94|||
pharmacy|UU|501.94|502.72|||
compounded|UU|502.72|503.5|||
methotrexate|UU|503.5|504.4|||
that|UU|504.82|505.12|||
has|UU|505.12|505.27|||
been|UU|505.27|505.45|||
injected|UU|505.45|506.02|||
into|UU|506.02|506.23|||
the|UU|506.23|506.38|||
eye|UU|506.38|506.72|.||
We|UU|507.55|507.76|||
have|UU|507.76|507.85|||
recently|UU|507.85|508.3|||
filed|UU|508.3|508.78|||
for|UU|508.78|508.99|||
orphan|UU|508.99|509.38|||
drug|UU|509.38|509.65|||
designation|UU|509.65|510.49|||
for|UU|510.79|511.0|||
ATX|UU|511.0|511.42|||
twenty|UU|511.42|511.66|||
one|UU|511.66|511.81|||
ninety|UU|511.81|512.08|||
one|UU|512.08|512.44|||
in|UU|512.59|512.77|||
PRL|UU|512.83|513.67|.||
Turning|UU|515.73|516.06|||
to|UU|516.06|516.18|||
our|UU|516.18|516.3|||
systemic|UU|516.3|516.81|||
disease|UU|516.81|517.23|||
programs|UU|517.23|517.89|,||
we|UU|517.89|518.04|||
are|UU|518.04|518.13|||
very|UU|518.13|518.49|||
excited|UU|518.49|519.0|||
about|UU|519.0|519.27|||
ADX|UU|519.27|519.64|||
twenty|UU|519.75|520.18|||
six|UU|520.65|521.04|||
to|UU|521.04|521.22|||
nine|UU|521.22|521.67|,||
which|UU|521.67|521.94|||
to|UU|521.94|522.18|||
our|UU|522.18|522.39|||
knowledge|UU|522.39|523.02|||
is|UU|523.02|523.23|||
the|UU|523.23|523.38|||
first|UU|523.38|524.07|||
systemically|UU|524.07|524.91|||
available|UU|524.91|525.48|||
RASFF|UU|525.48|525.93|||
inhibitor|UU|525.93|526.47|||
in|UU|527.07|527.23|||
clinical|UU|527.26|527.67|||
testing|UU|527.67|528.09|||
of|UU|528.09|528.18|||
which|UU|528.18|528.48|||
represents|UU|528.48|529.17|||
the|UU|529.17|529.29|||
first|UU|529.29|529.74|||
time|UU|529.74|530.25|||
since|UU|530.25|530.5|||
Pendergraph|UU|530.5|531.18|||
inhibition|UU|531.18|531.81|||
has|UU|532.32|532.68|||
been|UU|532.68|532.83|||
assessed|UU|532.83|533.22|||
clinically|UU|533.22|533.88|,||
marking|UU|534.72|535.35|||
an|UU|535.35|535.47|||
exciting|UU|535.47|536.07|||
new|UU|536.07|536.28|||
milestone|UU|536.28|537.03|||
in|UU|537.03|537.12|||
the|UU|537.12|537.18|||
development|UU|537.18|537.84|||
of|UU|537.84|537.96|||
this|UU|537.96|538.17|||
novel|UU|538.17|538.8|||
mechanism|UU|538.8|539.43|||
of|UU|539.43|539.55|||
action|UU|539.55|540.0|.||
And|UU|540.93|541.18|||
I|UU|541.2|541.44|.||
N|UU|541.44|541.59|||
d|UU|541.59|541.89|||
has|UU|541.92|542.13|||
been|UU|542.13|542.34|||
filed|UU|542.34|542.82|||
with|UU|542.82|542.94|||
the|UU|542.94|543.06|||
FDA|UU|543.06|543.66|||
for|UU|543.66|543.87|||
phase|UU|543.87|544.35|||
two|UU|544.35|544.62|||
clinical|UU|544.62|545.04|||
testing|UU|545.04|545.52|||
of|UU|545.52|545.64|||
eighty|UU|545.64|545.82|||
six|UU|545.97|546.21|||
to|UU|546.21|546.36|||
nine|UU|546.36|546.81|||
in|UU|547.26|547.53|||
patients|UU|547.53|548.01|||
with|UU|548.01|548.16|||
covid-19|UU|548.16|549.33|||
in|UU|549.87|550.11|||
order|UU|550.11|550.38|||
to|UU|550.38|550.5|||
prevent|UU|550.5|550.92|||
cytokine|UU|550.92|551.49|||
release|UU|551.49|551.85|||
syndrome|UU|551.85|552.54|||
and|UU|552.93|553.23|||
respiratory|UU|553.23|553.89|||
compromise|UU|553.89|554.7|.||
Clinical|UU|555.12|555.48|||
development|UU|555.48|556.02|||
is|UU|556.02|556.17|||
expected|UU|556.17|556.68|||
to|UU|556.68|556.8|||
begin|UU|556.8|557.34|||
this|UU|557.76|558.03|||
year|UU|558.03|558.39|.||
In|UU|559.84|560.05|||
an|UU|560.05|560.2|||
animal|UU|560.2|560.56|||
model|UU|560.56|560.95|,||
a|UU|560.95|561.04|||
cytokine|UU|561.04|561.7|||
storm|UU|561.7|562.27|,||
eighty|UU|562.27|562.57|||
six|UU|562.76|563.05|||
to|UU|563.05|563.26|||
nine|UU|563.26|563.62|||
demonstrated|UU|563.62|564.37|||
a|UU|564.37|564.49|||
broad|UU|564.49|565.15|||
and|UU|565.15|565.3|||
highly|UU|565.3|565.84|||
statistically|UU|565.84|566.65|||
significant|UU|566.65|567.28|||
reduction|UU|567.28|567.82|||
in|UU|567.82|567.94|||
cytokine|UU|567.94|568.57|||
levels|UU|568.57|569.02|,||
including|UU|569.35|570.07|||
TNF|UU|570.07|570.52|,||
Alpha|UU|570.52|570.82|,||
Interferon|UU|570.82|571.45|,||
Gamma|UU|571.45|571.81|||
and|UU|571.81|571.93|||
I|UU|571.93|572.05|||
17|UU|572.17|572.98|,||
while|UU|573.4|573.73|||
up|UU|573.73|573.93|||
regulating|UU|573.94|574.51|||
the|UU|574.51|574.6|||
key|UU|574.6|574.99|||
antiinflammatory|UU|574.99|576.19|||
cytokine|UU|576.19|576.94|||
10|UU|577.43|577.82|||
10|UU|577.82|577.84|.||
The|UU|578.83|579.01|||
data|UU|579.01|579.49|||
suggests|UU|579.49|579.97|||
that|UU|579.97|580.15|||
rasped|UU|580.15|580.57|||
inhibitors|UU|580.57|581.17|||
have|UU|581.17|581.41|||
the|UU|581.41|581.5|||
potential|UU|581.5|582.1|||
to|UU|582.1|582.28|||
represent|UU|582.28|583.03|||
immunological|UU|583.03|583.93|||
switches|UU|583.93|584.62|,||
which|UU|585.22|585.49|||
may|UU|585.49|585.76|||
modulate|UU|585.76|586.42|||
immune|UU|586.42|586.96|||
systems|UU|586.96|587.83|||
from|UU|587.83|588.1|||
pro|UU|588.1|588.46|||
inflammatory|UU|588.46|589.21|||
states|UU|589.21|589.66|||
to|UU|590.11|590.35|||
antiinflammatory|UU|590.35|591.49|||
states|UU|591.49|591.98|.||
In|UU|593.68|593.89|||
the|UU|593.89|593.98|||
fourth|UU|593.98|594.31|||
quarter|UU|594.31|594.64|||
of|UU|594.64|594.73|||
this|UU|594.73|594.97|||
year|UU|594.97|595.25|.||
We|UU|595.27|595.45|||
also|UU|595.45|595.9|||
expect|UU|595.9|596.32|||
to|UU|596.32|596.44|||
initiate|UU|596.44|596.92|||
clinical|UU|596.92|597.31|||
trials|UU|597.31|597.85|||
of|UU|597.85|597.97|||
eighty|UU|597.97|598.21|||
six|UU|598.37|598.63|||
to|UU|598.63|598.84|||
nine|UU|598.84|599.17|||
and|UU|599.17|599.29|||
psoriasis|UU|599.29|600.34|,||
an|UU|600.34|600.55|||
autoimmune|UU|600.55|601.09|||
disease|UU|601.09|601.66|||
and|UU|602.26|602.65|||
atopic|UU|602.65|603.25|||
asthma|UU|603.25|603.85|||
and|UU|603.85|604.0|||
allergic|UU|604.0|604.45|||
disease|UU|604.45|605.08|||
in|UU|605.89|606.22|||
combination|UU|606.22|607.06|||
trials|UU|607.24|607.84|||
and|UU|607.84|608.02|||
covid-19|UU|608.02|609.1|||
psoriasis|UU|609.1|609.85|||
and|UU|609.85|610.0|||
asthma|UU|610.0|610.65|||
to|UU|610.66|610.72|||
cover|UU|610.9|611.35|||
the|UU|611.35|611.47|||
gamut|UU|611.47|612.13|||
of|UU|612.13|612.4|||
inflammation|UU|612.4|613.15|.||
And|UU|613.15|613.24|||
the|UU|613.24|613.33|||
results|UU|613.33|613.84|||
of|UU|613.84|613.93|||
the|UU|613.93|614.02|||
trials|UU|614.02|614.53|||
will|UU|614.53|614.65|||
characterize|UU|614.65|615.55|||
the|UU|615.55|615.67|||
immune|UU|615.67|616.0|||
modulating|UU|616.0|616.6|||
activity|UU|616.6|617.2|||
of|UU|617.53|617.78|||
eighty|UU|617.78|618.01|||
six|UU|618.2|618.43|||
to|UU|618.43|618.61|||
nine|UU|618.61|619.09|||
and|UU|619.33|619.72|||
rasff|UU|619.72|620.14|||
inhibition|UU|620.14|620.83|||
more|UU|621.28|621.61|||
generally|UU|621.61|622.18|.||
Switching|UU|624.66|625.08|||
to|UU|625.08|625.17|||
ADX|UU|625.17|625.57|||
16|UU|625.62|626.16|||
12|UU|626.16|626.79|||
are|UU|626.79|626.97|||
novel|UU|626.97|627.45|||
HSP|UU|627.45|628.02|||
90|UU|628.02|628.35|||
inhibitor|UU|628.35|628.89|||
enrollment|UU|629.52|630.27|||
has|UU|630.27|630.48|||
been|UU|630.48|630.72|||
completed|UU|630.72|631.29|||
and|UU|631.29|631.41|||
the|UU|631.41|631.47|||
investigator|UU|631.47|632.16|||
sponsored|UU|632.16|632.73|||
phase|UU|632.73|633.15|||
two|UU|633.15|633.51|||
Udara|UU|633.51|634.06|||
show|UU|634.06|634.2|||
trial|UU|634.23|634.83|||
in|UU|635.13|635.34|||
ovarian|UU|635.34|635.82|||
cancer|UU|635.82|636.35|||
regarding|UU|637.53|638.07|||
the|UU|638.07|638.22|||
ATX|UU|638.22|638.51|||
16|UU|638.61|639.02|||
12|UU|639.03|639.42|||
covid-19|UU|639.42|640.38|||
program|UU|640.38|641.07|||
consistent|UU|641.52|642.18|||
with|UU|642.18|642.33|||
FDA|UU|642.33|642.81|||
feedback|UU|642.81|643.53|,||
additional|UU|643.53|644.19|||
preclinical|UU|644.19|644.91|||
antiviral|UU|644.91|645.63|||
testing|UU|645.63|646.08|,||
V-Tech|UU|646.08|646.43|||
16|UU|646.47|646.89|||
12|UU|646.89|647.4|||
against|UU|647.58|648.09|||
sars-cov-2|UU|648.09|649.38|.||
The|UU|649.74|649.92|||
virus|UU|649.92|650.31|||
that|UU|650.31|650.43|||
causes|UU|650.43|650.85|||
covid-19|UU|650.85|651.75|||
will|UU|652.23|652.38|||
be|UU|652.38|652.53|||
performed|UU|652.53|653.07|||
by|UU|653.07|653.19|||
the|UU|653.19|653.28|||
National|UU|653.28|653.7|||
Institute|UU|653.7|654.12|||
of|UU|654.12|654.21|||
Allergy|UU|654.21|654.66|||
and|UU|654.66|654.75|||
Infectious|UU|654.75|655.26|||
Diseases|UU|655.26|655.92|,||
which|UU|656.43|656.82|||
has|UU|656.82|657.06|||
accepted|UU|657.06|657.63|||
our|UU|657.63|657.81|||
request|UU|657.81|658.32|||
to|UU|658.32|658.47|||
evaluate|UU|658.47|659.04|||
ATX|UU|659.05|659.29|||
16|UU|659.37|659.82|,||
12|UU|659.82|660.33|||
and|UU|660.63|660.87|||
in|UU|660.87|660.99|||
vivo|UU|660.99|661.38|||
models|UU|661.38|661.86|.||
We|UU|662.73|662.82|||
plan|UU|662.82|663.06|||
to|UU|663.06|663.12|||
update|UU|663.12|663.6|||
on|UU|663.66|663.84|||
the|UU|663.84|663.96|||
16|UU|664.23|664.71|||
12|UU|664.71|665.04|||
covid|UU|665.04|665.4|||
program|UU|665.4|666.0|||
by|UU|666.57|666.81|||
the|UU|666.81|666.93|||
end|UU|666.93|667.23|||
of|UU|667.23|667.41|||
twenty|UU|667.41|667.89|||
twenty|UU|668.37|668.91|.||
We|UU|672.83|673.04|||
approach|UU|673.04|673.43|||
the|UU|673.43|673.58|||
midpoint|UU|673.58|674.27|||
of|UU|674.3|674.66|||
the|UU|674.66|674.9|||
third|UU|674.9|675.26|||
quarter|UU|675.26|675.77|||
in|UU|676.16|676.46|||
a|UU|676.46|676.55|||
strong|UU|676.55|677.12|||
financial|UU|677.12|677.63|||
position|UU|677.63|678.17|,||
enhancing|UU|679.19|679.82|||
our|UU|679.82|680.0|||
flexibility|UU|680.12|680.93|||
with|UU|680.93|681.14|||
recent|UU|681.14|681.59|||
common|UU|681.59|682.07|||
stock|UU|682.07|682.46|||
sales|UU|682.46|682.96|||
to|UU|682.97|683.06|||
to|UU|683.09|683.39|||
health|UU|683.39|683.66|||
care|UU|683.66|683.93|||
focused|UU|683.93|684.38|||
funds|UU|684.38|684.83|,||
perceptive|UU|684.83|685.4|||
advisers|UU|685.4|686.12|||
and|UU|686.12|686.45|||
affinity|UU|686.45|686.87|||
partners|UU|686.87|687.47|.||
These|UU|688.43|688.67|||
transactions|UU|688.67|689.36|||
raise|UU|689.36|689.81|||
gross|UU|689.81|690.2|||
proceeds|UU|690.2|690.92|||
of|UU|690.92|691.04|||
approximately|UU|691.04|691.82|||
nineteen|UU|691.82|692.33|||
point|UU|692.33|692.63|||
five|UU|692.63|693.02|||
million|UU|693.02|693.62|,||
completing|UU|693.62|694.49|||
our|UU|694.52|694.79|||
previously|UU|694.79|695.48|||
announced|UU|695.48|695.96|||
at|UU|695.96|696.2|||
the|UU|696.2|696.29|||
market|UU|696.29|696.74|||
offering|UU|696.74|697.31|||
program|UU|697.49|698.12|.||
We|UU|698.99|699.2|||
expect|UU|699.2|699.62|||
our|UU|699.62|699.74|||
cash|UU|699.74|700.07|||
runway|UU|700.07|700.43|||
to|UU|700.43|700.52|||
be|UU|700.52|700.67|||
sufficient|UU|700.67|701.12|||
to|UU|701.12|701.24|||
fund|UU|701.24|701.51|||
operations|UU|701.51|702.2|||
through|UU|702.2|702.41|||
twenty|UU|702.41|702.86|||
twenty|UU|702.86|703.25|||
two|UU|703.25|703.64|,||
including|UU|704.3|705.11|||
potential|UU|705.11|705.83|||
reproachful|UU|705.86|706.47|||
app|UU|706.49|706.65|||
approval|UU|706.67|707.27|||
and|UU|707.72|707.96|||
dry|UU|707.96|708.26|||
eye|UU|708.26|708.41|||
disease|UU|708.41|709.07|||
and|UU|709.37|709.61|||
allergic|UU|709.61|709.97|||
conjunctivitis|UU|709.97|710.84|.||
Now|UU|712.82|713.08|||
that|UU|713.21|713.36|||
I'd|UU|713.39|713.48|||
like|UU|713.48|713.63|||
to|UU|713.63|713.72|||
turn|UU|713.72|713.99|||
the|UU|713.99|714.05|||
call|UU|714.05|714.32|||
back|UU|714.32|714.56|||
over|UU|714.56|714.77|||
to|UU|714.77|714.86|||
Josh|UU|714.86|715.37|||
for|UU|715.37|715.58|||
the|UU|715.58|715.82|||
Financial|UU|715.82|716.3|||
Review|UU|716.3|716.72|.||
Thank|UU|720.48|720.76|||
God|UU|721.42|721.75|||
for|UU|722.29|722.5|||
the|UU|722.5|722.56|||
quarter|UU|722.56|722.98|||
ended|UU|722.98|723.25|||
June|UU|723.25|723.58|||
30|UU|723.58|724.03|,||
2020|UU|724.03|724.95|,||
we|UU|725.17|725.41|||
reported|UU|725.41|725.86|||
a|UU|725.86|725.95|||
net|UU|725.95|726.19|||
loss|UU|726.19|726.64|||
of|UU|726.64|726.88|||
seven|UU|726.88|727.36|||
point|UU|727.36|727.6|||
five|UU|727.6|727.93|||
dollars|UU|727.93|728.17|||
million|UU|728.17|728.65|,||
compared|UU|728.68|729.13|||
with|UU|729.13|729.28|||
a|UU|729.28|729.34|||
net|UU|729.34|729.55|||
loss|UU|729.55|729.91|||
of|UU|729.91|730.0|||
thirteen|UU|730.0|730.51|||
point|UU|730.51|730.78|||
three|UU|730.78|731.08|||
dollars|UU|731.08|731.35|||
million|UU|731.35|731.86|||
for|UU|732.19|732.4|||
the|UU|732.4|732.49|||
quarter|UU|732.49|732.85|||
ended|UU|732.85|733.15|||
June|UU|733.15|733.42|||
30|UU|733.42|733.75|.||
Twenty|UU|733.75|734.05|||
nineteen|UU|734.05|734.59|||
net|UU|735.7|736.06|||
loss|UU|736.06|736.3|||
per|UU|736.3|736.48|||
share|UU|736.48|736.72|||
with|UU|736.72|736.87|||
twenty|UU|736.87|737.17|||
five|UU|737.17|737.41|||
cents|UU|737.41|737.77|||
for|UU|738.1|738.34|||
the|UU|738.34|738.4|||
quarter|UU|738.4|738.73|||
ended|UU|738.73|738.97|||
June|UU|738.97|739.27|||
30|UU|739.27|739.63|||
twenty|UU|739.63|739.99|||
twenty|UU|739.99|740.5|,||
compared|UU|740.74|741.25|||
with|UU|741.25|741.4|||
forty|UU|741.4|741.73|||
nine|UU|741.73|741.97|||
cents|UU|741.97|742.27|||
for|UU|742.27|742.39|||
the|UU|742.39|742.51|||
same|UU|742.51|742.78|||
period|UU|742.78|743.08|||
in|UU|743.08|743.2|||
twenty|UU|743.2|743.5|||
nineteen|UU|743.5|744.05|.||
Losses|UU|745.03|745.66|||
have|UU|745.66|745.84|||
resulted|UU|745.84|746.38|||
from|UU|746.38|746.65|||
the|UU|746.65|746.74|||
cost|UU|746.74|747.1|||
of|UU|747.1|747.19|||
clinical|UU|747.19|747.58|||
trials|UU|747.58|748.12|||
and|UU|748.21|748.45|||
research|UU|748.45|748.87|||
and|UU|748.87|748.96|||
development|UU|748.96|749.41|||
program|UU|749.41|749.98|,||
as|UU|750.31|750.58|||
well|UU|750.58|750.82|||
as|UU|750.82|750.94|||
from|UU|750.94|751.15|||
general|UU|751.15|751.63|||
and|UU|751.63|751.81|||
administrative|UU|751.81|752.41|||
expenses|UU|752.41|753.07|.||
Research|UU|754.48|755.02|||
and|UU|755.02|755.11|||
development|UU|755.11|755.56|||
expenses|UU|755.56|756.13|||
were|UU|756.13|756.25|||
four|UU|756.25|756.49|||
point|UU|756.49|756.76|||
nine|UU|756.76|757.03|||
dollars|UU|757.03|757.27|||
million|UU|757.27|757.71|||
for|UU|757.72|757.87|||
the|UU|757.87|757.96|||
quarter|UU|757.96|758.32|||
ended|UU|758.32|758.56|||
June|UU|758.56|758.8|||
30|UU|758.8|759.13|||
twenty|UU|759.13|759.49|||
twenty|UU|759.49|760.0|,||
compared|UU|760.33|760.81|||
with|UU|760.81|760.99|||
ten|UU|760.99|761.26|||
point|UU|761.26|761.5|||
seven|UU|761.5|761.86|||
dollars|UU|761.86|762.1|||
million|UU|762.1|762.55|||
for|UU|762.55|762.67|||
the|UU|762.67|762.76|||
same|UU|762.76|763.06|||
period|UU|763.06|763.36|||
in|UU|763.36|763.45|||
twenty|UU|763.45|763.78|||
nineteen|UU|763.78|764.35|.||
The|UU|764.98|765.13|||
decrease|UU|765.13|765.73|||
of|UU|765.73|765.82|||
five|UU|765.82|766.09|||
point|UU|766.09|766.36|||
eight|UU|766.36|766.57|||
dollars|UU|766.57|766.81|||
million|UU|766.81|767.27|||
is|UU|767.29|767.47|||
primarily|UU|767.47|768.13|||
related|UU|768.13|768.52|||
to|UU|768.52|768.67|||
a|UU|768.67|768.73|||
reduction|UU|768.73|769.39|||
in|UU|769.87|770.14|||
clinical|UU|770.14|770.77|||
and|UU|770.77|770.95|||
preclinical|UU|770.96|771.61|||
development|UU|771.61|772.27|,||
manufacturing|UU|772.45|773.44|||
and|UU|773.44|773.62|||
personnel|UU|773.62|774.1|||
costs|UU|774.1|774.48|.||
General|UU|776.04|776.35|||
and|UU|776.66|776.74|||
administrative|UU|776.74|777.37|||
expenses|UU|777.37|777.88|||
were|UU|777.88|778.0|||
two|UU|778.0|778.24|||
point|UU|778.24|778.54|||
two|UU|778.54|778.79|||
million|UU|778.79|779.11|||
dollars|UU|779.11|779.25|||
for|UU|779.44|779.56|||
the|UU|779.56|779.65|||
quarter|UU|779.65|779.95|||
ended|UU|779.95|780.19|||
June|UU|780.19|780.4|||
30|UU|780.4|780.73|,||
2020|UU|780.73|781.57|,||
compared|UU|781.84|782.29|||
with|UU|782.29|782.44|||
three|UU|782.44|782.71|||
point|UU|782.71|782.98|||
one|UU|782.98|783.22|||
dollars|UU|783.22|783.46|||
million|UU|783.46|783.88|||
for|UU|783.88|784.0|||
the|UU|784.0|784.09|||
same|UU|784.09|784.39|||
period|UU|784.39|784.66|||
in|UU|784.66|784.75|||
twenty|UU|784.75|785.05|||
nineteen|UU|785.05|785.59|.||
The|UU|786.58|786.76|||
decrease|UU|786.76|787.39|||
of|UU|787.39|787.48|||
nine|UU|787.48|787.75|||
hundred|UU|787.75|787.99|||
thousand|UU|787.99|788.38|||
dollars|UU|788.38|788.86|||
is|UU|788.86|788.98|||
due|UU|788.98|789.13|||
to|UU|789.13|789.34|||
lower|UU|789.34|789.64|||
personnel|UU|789.64|790.09|||
related|UU|790.09|790.48|||
costs|UU|790.48|790.9|,||
including|UU|791.11|791.65|||
stock|UU|791.65|792.01|||
based|UU|792.01|792.28|||
compensation|UU|792.28|793.18|||
and|UU|793.33|793.6|||
other|UU|793.6|793.84|||
miscellaneous|UU|793.84|794.56|||
administrative|UU|794.56|795.25|||
costs|UU|795.25|795.64|.||
In|UU|797.26|797.47|||
the|UU|797.47|797.56|||
second|UU|797.56|797.92|||
quarter|UU|797.92|798.19|||
of|UU|798.19|798.28|||
twenty|UU|798.28|798.58|||
twenty|UU|798.58|799.02|,||
total|UU|799.72|800.02|||
operating|UU|800.02|800.35|||
expenses|UU|800.35|800.83|||
were|UU|800.83|800.92|||
seven|UU|800.92|801.22|||
point|UU|801.22|801.49|||
one|UU|801.49|801.7|||
dollars|UU|801.7|801.94|||
million|UU|801.94|802.51|,||
compared|UU|802.63|803.05|||
with|UU|803.05|803.2|||
total|UU|803.2|803.53|||
operating|UU|803.53|803.95|||
expenses|UU|803.95|804.46|||
of|UU|804.46|804.55|||
thirteen|UU|804.55|805.03|||
point|UU|805.03|805.3|||
seven|UU|805.3|805.69|||
dollars|UU|805.69|805.93|||
million|UU|805.93|806.47|||
for|UU|806.68|806.86|||
the|UU|806.86|806.95|||
same|UU|806.95|807.22|||
period|UU|807.22|807.49|||
in|UU|807.49|807.58|||
twenty|UU|807.58|807.85|||
nineteen|UU|807.85|808.39|||
as|UU|810.19|810.49|||
of|UU|810.49|810.61|||
June|UU|810.61|810.91|||
30|UU|810.91|811.24|.||
Twenty|UU|811.24|811.57|||
twenty|UU|811.57|811.98|||
cash|UU|812.23|812.83|,||
cash|UU|812.98|813.37|||
equivalents|UU|813.37|813.88|||
and|UU|814.3|814.57|||
marketable|UU|814.57|815.02|||
securities|UU|815.02|815.62|||
were|UU|815.89|816.07|||
sixty|UU|816.07|816.46|||
six|UU|816.46|816.79|||
point|UU|816.79|817.03|||
two|UU|817.03|817.21|||
million|UU|817.22|817.54|||
dollars|UU|817.54|817.99|.||
Subsequent|UU|818.68|819.4|||
to|UU|819.4|819.52|||
June|UU|819.52|819.97|||
30|UU|819.97|820.39|,||
twenty|UU|820.39|820.69|||
twenty|UU|820.69|821.11|||
twenty|UU|821.38|821.8|||
five|UU|821.8|822.16|||
point|UU|822.16|822.4|||
two|UU|822.4|822.58|||
million|UU|822.58|822.88|||
dollars|UU|822.88|823.19|||
in|UU|823.36|823.54|||
cash|UU|823.54|823.96|||
was|UU|823.96|824.17|||
received|UU|824.17|824.65|||
from|UU|824.71|825.16|||
at|UU|825.58|825.91|||
the|UU|825.91|826.0|||
market|UU|826.0|826.42|,||
offering|UU|826.42|826.87|||
program|UU|826.87|827.35|||
sales|UU|827.35|827.68|||
to|UU|827.68|827.86|||
perceptive|UU|827.86|828.4|||
advisors|UU|828.4|829.09|,||
avidity|UU|829.39|829.95|||
partners|UU|829.96|830.62|||
and|UU|830.62|830.89|||
other|UU|830.89|831.1|||
investors|UU|831.1|831.73|.||
Based|UU|833.86|834.25|||
on|UU|834.25|834.37|||
current|UU|834.37|834.67|||
operating|UU|834.67|835.15|||
plans|UU|835.15|835.57|,||
cash|UU|835.72|836.26|,||
cash|UU|836.44|836.8|||
equivalents|UU|836.8|837.31|||
and|UU|837.46|837.7|||
marketable|UU|837.7|838.12|||
securities|UU|838.12|838.75|||
as|UU|839.02|839.32|||
of|UU|839.32|839.44|||
June|UU|839.44|839.68|||
30|UU|839.68|840.04|,||
2020|UU|840.04|840.97|,||
plus|UU|841.27|841.72|||
the|UU|841.84|842.02|||
additional|UU|842.02|842.59|||
at|UU|842.59|842.86|||
the|UU|842.86|842.98|||
market|UU|842.98|843.49|||
offering|UU|843.64|844.12|||
program|UU|844.12|844.54|,||
proceeds|UU|844.54|845.14|||
are|UU|845.44|845.65|||
expected|UU|845.65|846.19|||
to|UU|846.19|846.28|||
be|UU|846.28|846.43|||
sufficient|UU|846.43|847.03|||
to|UU|847.03|847.15|||
fund|UU|847.15|847.45|||
operations|UU|847.45|848.17|||
through|UU|848.17|848.53|||
the|UU|848.53|848.68|||
end|UU|848.68|848.83|||
of|UU|848.83|848.92|||
twenty|UU|848.92|849.22|||
twenty|UU|849.22|849.53|||
two|UU|849.55|849.94|,||
including|UU|850.24|850.9|||
potential|UU|850.9|851.44|||
FDA|UU|851.44|851.8|||
approvals|UU|851.8|852.31|||
for|UU|852.31|852.56|||
proselyte|UU|852.61|853.35|||
and|UU|853.6|853.84|||
dry|UU|853.84|854.14|||
disease|UU|854.14|854.65|||
and|UU|854.65|854.86|||
allergic|UU|854.86|855.25|||
conjunctivitis|UU|855.25|856.15|.||
Assuming|UU|856.45|856.93|||
positive|UU|856.93|857.5|||
clinical|UU|857.5|857.92|||
trial|UU|857.92|858.19|||
results|UU|858.19|858.61|||
and|UU|858.88|859.15|||
planned|UU|859.15|859.54|||
NDA|UU|859.54|859.96|||
submission|UU|859.96|860.59|||
acceptances|UU|860.77|861.7|||
and|UU|861.7|861.85|||
approval|UU|861.85|862.38|.||
Use|UU|863.89|864.22|||
of|UU|864.22|864.34|||
cash|UU|864.34|864.76|,||
cash|UU|864.76|865.09|||
equivalents|UU|865.09|865.54|||
and|UU|865.75|865.99|||
marketable|UU|865.99|866.41|||
securities|UU|866.41|866.95|||
are|UU|866.95|867.07|||
also|UU|867.07|867.46|||
expected|UU|867.46|868.09|||
to|UU|868.36|868.6|||
include|UU|868.6|868.93|||
the|UU|868.93|869.02|||
continuation|UU|869.02|869.77|||
of|UU|869.77|869.86|||
Part|UU|869.86|870.22|||
one|UU|870.22|870.58|||
of|UU|870.76|870.97|||
the|UU|871.0|871.06|||
Phase|UU|871.06|871.39|||
three|UU|871.39|871.66|||
guard|UU|871.66|871.93|||
trial|UU|871.93|872.29|||
in|UU|872.29|872.38|||
PBR|UU|872.38|873.04|||
and|UU|873.22|873.49|||
phase|UU|873.49|873.85|||
two|UU|873.85|874.06|||
clinical|UU|874.06|874.48|||
testing|UU|874.48|875.14|||
of|UU|875.17|875.38|||
eighty|UU|875.38|875.59|||
six|UU|875.78|875.97|||
to|UU|876.01|876.19|||
nine|UU|876.19|876.61|||
in|UU|876.73|877.03|||
orally|UU|877.03|877.48|||
administered|UU|877.48|878.2|||
rasped|UU|878.26|878.77|||
inhibitor|UU|878.77|879.34|||
in|UU|879.46|879.7|||
inflammatory|UU|879.7|880.39|||
diseases|UU|880.39|881.03|.||
Now|UU|881.95|882.33|||
turn|UU|882.34|882.58|||
the|UU|882.58|882.67|||
call|UU|882.67|882.88|||
back|UU|882.88|883.15|||
to|UU|883.15|883.27|||
Todd|UU|883.27|883.57|||
for|UU|883.57|883.69|||
closing|UU|883.69|884.08|||
comments|UU|884.08|884.44|.||
Thanks|UU|891.14|891.5|,||
Josh|UU|891.5|891.97|,||
we|UU|892.34|892.58|||
have|UU|892.58|892.76|||
a|UU|892.76|892.82|||
number|UU|892.82|893.24|||
of|UU|893.24|893.6|||
milestones|UU|893.6|894.41|||
planned|UU|894.41|894.77|||
for|UU|894.77|894.95|||
the|UU|894.95|895.04|||
second|UU|895.04|895.34|||
half|UU|895.34|895.67|||
of|UU|895.67|895.79|||
twenty|UU|895.79|896.12|||
twenty|UU|896.12|896.51|||
and|UU|897.35|897.65|||
look|UU|897.65|897.8|||
forward|UU|897.8|898.04|||
to|UU|898.04|898.1|||
executing|UU|898.1|898.67|||
on|UU|898.67|898.82|||
our|UU|898.82|898.94|||
clinical|UU|898.94|899.27|||
development|UU|899.27|899.66|||
strategy|UU|899.66|900.2|||
across|UU|900.2|900.65|||
our|UU|900.65|900.86|||
ocular|UU|900.86|901.46|||
and|UU|901.46|901.88|||
systemic|UU|902.03|902.63|||
programs|UU|902.63|903.26|,||
looking|UU|904.28|904.58|||
at|UU|904.58|904.67|||
our|UU|904.67|904.83|||
E.R.|UU|904.84|905.15|||
calendar|UU|905.15|905.61|.||
Next|UU|905.63|905.87|||
week|UU|905.87|906.11|,||
we'll|UU|906.11|906.26|||
be|UU|906.26|906.47|||
presenting|UU|906.47|907.07|||
at|UU|907.07|907.25|||
the|UU|907.25|907.46|||
BTIG|UU|907.46|908.3|||
Virtual|UU|908.3|908.78|||
Biotechnology|UU|908.78|909.62|||
Conference|UU|909.62|910.19|||
and|UU|910.76|911.27|||
Wedbush|UU|911.72|912.38|||
Packard|UU|912.38|912.74|||
Virtual|UU|912.86|913.28|||
Health|UU|913.28|913.49|||
Care|UU|913.49|913.7|||
Conference|UU|913.7|914.27|.||
These|UU|915.26|915.5|||
events|UU|915.5|915.74|||
will|UU|915.74|915.86|||
be|UU|915.86|915.98|||
webcast|UU|915.98|916.67|.||
Please|UU|917.0|917.27|||
check|UU|917.27|917.54|||
the|UU|917.54|917.66|||
events|UU|917.66|917.99|||
and|UU|917.99|918.08|||
presentation|UU|918.08|918.74|||
section|UU|918.75|919.13|||
of|UU|919.13|919.22|||
our|UU|919.22|919.34|||
website|UU|919.34|919.94|||
for|UU|920.57|920.75|||
details|UU|920.75|921.28|.||
We|UU|922.37|922.58|||
always|UU|922.58|922.82|||
look|UU|922.82|922.97|||
forward|UU|922.97|923.15|||
to|UU|923.15|923.24|||
meeting|UU|923.24|923.48|||
with|UU|923.48|923.6|||
investors|UU|923.6|924.14|||
and|UU|924.14|924.26|||
hope|UU|924.26|924.47|||
to|UU|924.47|924.56|||
connect|UU|924.56|924.83|||
with|UU|924.83|924.98|||
you|UU|924.98|925.34|||
at|UU|925.37|925.58|||
these|UU|925.58|926.0|||
or|UU|926.0|926.27|||
other|UU|926.27|926.72|||
upcoming|UU|927.14|927.65|||
events|UU|927.65|928.07|.||
As|UU|929.87|930.2|||
always|UU|930.2|930.68|,||
we|UU|930.68|930.83|||
remain|UU|930.83|931.19|||
committed|UU|931.19|931.52|||
to|UU|931.52|931.58|||
executing|UU|931.58|932.12|||
efficiently|UU|932.12|932.63|||
in|UU|932.63|932.75|||
our|UU|932.75|932.84|||
strategic|UU|932.84|933.32|||
plan|UU|933.32|933.71|||
and|UU|933.71|933.8|||
bringing|UU|933.8|934.13|||
to|UU|934.13|934.25|||
market|UU|934.25|934.64|||
novel|UU|934.64|934.94|||
therapies|UU|934.94|935.54|||
that|UU|935.54|935.69|||
improve|UU|935.69|936.13|||
improve|UU|936.14|936.53|||
the|UU|936.53|936.62|||
lives|UU|936.62|937.01|||
of|UU|937.01|937.07|||
patients|UU|937.07|937.55|||
with|UU|937.55|937.7|||
serious|UU|937.7|938.27|||
unmet|UU|938.69|939.11|||
medical|UU|939.11|939.47|||
needs|UU|939.47|939.92|.||
With|UU|940.61|940.8|||
that|UU|940.82|941.18|,||
Josh|UU|941.18|941.69|,||
Dave|UU|941.69|942.02|||
and|UU|942.02|942.11|||
I|UU|942.11|942.26|||
will|UU|942.26|942.35|||
be|UU|942.35|942.5|||
happy|UU|942.5|943.01|||
to|UU|943.22|943.4|||
take|UU|943.4|943.61|||
your|UU|943.61|943.7|||
questions|UU|943.7|944.27|.||
Operator|UU|944.51|945.08|,||
at|UU|945.77|946.04|||
this|UU|946.04|946.22|||
time|UU|946.22|946.46|,||
if|UU|946.46|946.58|||
you|UU|946.58|946.67|||
would|UU|946.67|946.79|||
like|UU|946.79|946.94|||
to|UU|946.94|947.06|||
ask|UU|947.06|947.33|||
a|UU|947.33|947.39|||
question|UU|947.39|947.81|,||
please|UU|947.81|948.11|,||
press|UU|948.11|948.38|||
star|UU|948.38|948.8|,||
then|UU|948.8|948.98|||
the|UU|948.98|949.07|||
number|UU|949.07|949.37|||
one|UU|949.37|949.61|||
on|UU|949.61|949.79|||
your|UU|949.79|949.91|||
telephone|UU|949.91|950.36|||
keypad|UU|950.36|950.93|,||
that|UU|950.93|951.14|||
is|UU|951.14|951.23|||
star|UU|951.23|951.5|||
one|UU|951.5|951.74|||
to|UU|951.74|951.86|||
ask|UU|951.86|952.16|||
a|UU|952.16|952.22|||
question|UU|952.22|952.78|.||
First|UU|953.45|953.75|||
question|UU|953.75|954.2|||
comes|UU|954.2|954.44|||
from|UU|954.44|954.65|||
the|UU|954.65|954.74|||
line|UU|954.74|955.1|||
of|UU|955.1|955.3|||
the|UU|955.31|955.38|||
Fed|UU|955.55|955.92|||
with|UU|955.94|956.12|||
Cantor|UU|956.12|956.78|.||
Hi|UU|958.62|959.13|,||
thanks|UU|959.13|959.49|||
for|UU|959.49|959.64|||
taking|UU|959.64|959.91|||
my|UU|959.91|960.03|||
questions|UU|960.03|960.66|||
here|UU|960.66|961.11|.||
So|UU|961.48|961.74|||
first|UU|961.74|962.04|||
question|UU|962.04|962.34|||
I|UU|962.34|962.43|||
have|UU|962.43|962.64|||
for|UU|962.64|962.85|||
you|UU|962.85|963.07|||
is|UU|963.07|963.2|,||
could|UU|963.24|963.42|||
you|UU|963.42|963.51|||
get|UU|963.51|963.72|||
into|UU|963.72|964.05|||
more|UU|964.05|964.29|||
detail|UU|964.29|964.84|||
how|UU|964.85|964.89|||
significant|UU|965.25|966.06|||
the|UU|966.06|966.21|||
FDA's|UU|966.21|966.84|||
recognition|UU|966.84|967.47|||
of|UU|967.47|967.59|||
Ralfe|UU|967.59|968.04|||
as|UU|968.43|968.7|||
a|UU|968.7|968.76|||
science|UU|968.76|969.12|||
or|UU|969.12|969.21|||
dry|UU|969.21|969.53|||
eye|UU|969.53|969.69|||
disease|UU|969.69|970.26|||
is|UU|970.35|970.8|||
and|UU|970.8|970.89|||
what|UU|970.89|971.01|||
that|UU|971.01|971.16|||
means|UU|971.16|971.55|||
for|UU|971.55|971.73|||
you|UU|971.73|971.94|||
in|UU|971.94|972.03|||
terms|UU|972.03|972.36|||
in|UU|972.36|972.54|||
terms|UU|972.54|972.72|||
of|UU|972.72|972.78|||
potential|UU|972.78|973.2|||
approval|UU|973.2|973.59|||
and|UU|973.59|973.68|||
market|UU|973.68|973.95|||
opportunity|UU|973.95|974.58|?||
And|UU|975.09|975.36|||
then|UU|975.36|975.57|||
the|UU|975.57|975.63|||
second|UU|975.63|975.93|||
question|UU|975.93|976.44|||
I|UU|976.44|976.5|||
have|UU|976.5|976.68|||
for|UU|976.68|976.83|||
you|UU|976.83|976.96|||
is|UU|976.98|977.1|||
on|UU|977.1|977.25|||
your|UU|977.25|977.4|||
covid|UU|977.4|977.73|||
trials|UU|977.73|978.19|,||
how|UU|978.45|978.72|||
adaptive|UU|978.72|979.56|||
are|UU|979.59|979.74|||
those|UU|979.74|979.98|||
trials|UU|979.98|980.49|||
in|UU|980.49|980.58|||
light|UU|980.58|980.73|||
of|UU|980.73|980.79|||
the|UU|980.79|980.88|||
constantly|UU|980.88|981.6|||
evolving|UU|981.6|982.32|||
landscape|UU|982.35|983.09|||
for|UU|983.09|983.19|||
the|UU|983.19|983.28|||
treatment|UU|983.28|983.73|||
of|UU|983.73|983.82|||
covid|UU|983.82|984.42|||
and|UU|984.9|985.17|||
then|UU|985.17|985.32|||
how|UU|985.32|985.59|||
enrollment|UU|985.59|986.1|||
gone|UU|986.1|986.46|?||
And|UU|986.46|986.61|||
then|UU|986.61|986.7|||
my|UU|986.7|986.82|||
last|UU|986.82|987.09|||
question|UU|987.09|987.48|||
here|UU|987.48|987.66|||
is|UU|987.66|987.78|||
you|UU|987.78|987.9|||
noted|UU|987.9|988.29|||
that|UU|988.29|988.44|||
there's|UU|988.44|988.68|||
been|UU|988.68|988.8|||
some|UU|988.8|988.98|||
headwinds|UU|988.98|989.4|,||
the|UU|989.4|989.49|||
clinical|UU|989.49|989.94|||
trial|UU|989.94|990.42|||
progression|UU|990.63|991.29|||
due|UU|991.29|991.44|||
to|UU|991.44|991.53|||
covid|UU|991.53|992.01|.||
Can|UU|992.01|992.16|||
you|UU|992.16|992.25|||
give|UU|992.25|992.43|||
more|UU|992.43|992.64|||
color|UU|992.64|992.88|||
on|UU|992.88|993.03|||
which|UU|993.03|993.21|||
trials|UU|993.21|993.57|||
may|UU|993.57|993.75|||
be|UU|993.75|993.9|||
impacted|UU|993.9|994.53|||
here|UU|994.53|994.82|?||
Thank|UU|994.83|995.13|||
you|UU|995.13|995.34|.||
Good|UU|997.35|997.5|||
morning|UU|997.5|997.74|,||
Louise|UU|997.74|998.16|,||
and|UU|998.16|998.64|||
thanks|UU|998.64|998.97|||
for|UU|998.97|999.09|||
your|UU|999.09|999.24|||
excellent|UU|999.24|999.6|||
questions|UU|999.6|1000.21|.||
The|UU|1000.98|1001.4|||
rapid|UU|1001.76|1002.23|||
development|UU|1002.3|1003.26|||
is|UU|1003.32|1003.97|||
a|UU|1003.98|1004.19|||
truly|UU|1004.19|1005.09|||
transformative|UU|1005.09|1006.11|||
for|UU|1006.35|1006.58|||
Alvera|UU|1006.6|1007.16|.||
Grasp|UU|1008.66|1009.28|||
is|UU|1009.29|1009.62|||
the|UU|1009.62|1009.83|||
pharmaceutical|UU|1009.83|1010.61|||
target|UU|1010.61|1011.18|||
upon|UU|1011.66|1012.2|||
which|UU|1012.2|1012.65|||
the|UU|1012.65|1012.86|||
company|UU|1012.86|1013.31|||
was|UU|1013.31|1013.55|||
founded|UU|1013.55|1014.18|||
many|UU|1014.18|1014.51|||
years|UU|1014.51|1014.81|||
ago|UU|1014.81|1015.26|.||
To|UU|1016.01|1016.31|||
our|UU|1016.31|1016.52|||
knowledge|UU|1016.52|1017.18|,||
no|UU|1017.18|1017.51|||
company|UU|1017.51|1018.05|||
has|UU|1018.05|1018.38|||
ever|UU|1018.38|1018.89|||
therapeutically|UU|1019.4|1020.36|||
addressed|UU|1020.36|1021.02|||
risk|UU|1021.11|1021.77|||
and|UU|1022.22|1022.61|||
yet|UU|1022.61|1023.12|||
represents|UU|1023.69|1024.59|||
a|UU|1025.13|1025.28|||
very|UU|1025.28|1025.58|||
broad|UU|1025.58|1026.06|||
based|UU|1026.06|1026.45|||
antiinflammatory|UU|1026.6|1027.86|||
approach|UU|1027.86|1028.31|||
that|UU|1028.31|1028.52|||
probably|UU|1028.52|1029.39|||
applies|UU|1029.39|1030.08|||
to|UU|1030.08|1030.29|||
many|UU|1030.29|1030.59|,||
many|UU|1030.59|1030.86|||
diseases|UU|1030.86|1031.46|,||
not|UU|1031.46|1031.7|||
only|UU|1031.7|1032.15|||
ocular|UU|1032.45|1032.99|||
diseases|UU|1032.99|1033.44|||
such|UU|1033.44|1033.65|||
as|UU|1033.65|1033.77|||
dry|UU|1033.77|1034.01|||
eye|UU|1034.01|1034.04|||
disease|UU|1034.04|1034.52|,||
but|UU|1034.52|1034.76|||
also|UU|1034.76|1035.48|||
systemic|UU|1036.08|1036.62|||
diseases|UU|1036.62|1037.21|.||
So|UU|1037.67|1038.15|||
for|UU|1038.15|1038.42|||
all|UU|1038.42|1038.57|||
those|UU|1038.57|1038.81|||
reasons|UU|1038.81|1039.2|,||
we|UU|1039.2|1039.35|||
were|UU|1039.35|1039.5|||
thrilled|UU|1039.5|1040.1|||
about|UU|1041.09|1041.54|||
the|UU|1041.54|1041.66|||
FDA's|UU|1041.66|1042.11|||
decision|UU|1042.11|1042.74|||
to|UU|1043.07|1043.25|||
classify|UU|1043.25|1043.97|||
Raab's|UU|1043.97|1044.42|||
as|UU|1044.42|1044.57|||
an|UU|1044.57|1044.66|||
objective|UU|1044.66|1045.14|||
sign|UU|1045.14|1045.68|||
of|UU|1045.68|1046.07|||
dry|UU|1046.07|1046.37|||
eye|UU|1046.37|1046.52|||
disease|UU|1046.52|1047.0|,||
which|UU|1047.27|1047.63|,||
as|UU|1047.63|1047.84|||
you|UU|1047.84|1047.99|||
know|UU|1047.99|1048.38|,||
is|UU|1048.38|1048.59|||
an|UU|1048.59|1048.68|||
inflammatory|UU|1048.68|1049.73|||
condition|UU|1050.54|1051.22|.||
What|UU|1051.8|1052.19|||
it|UU|1052.19|1052.34|||
means|UU|1052.34|1052.88|||
practically|UU|1052.88|1053.72|||
for|UU|1053.72|1053.9|||
the|UU|1053.9|1054.02|||
company|UU|1054.02|1054.71|||
is|UU|1054.98|1055.61|||
that|UU|1055.64|1056.15|||
the|UU|1056.27|1056.96|||
ongoing|UU|1057.5|1058.1|||
clinical|UU|1058.1|1058.52|||
trial|UU|1058.52|1058.79|||
of|UU|1058.79|1058.85|||
the|UU|1058.85|1059.06|||
clinical|UU|1059.06|1059.48|||
trials|UU|1059.48|1059.87|||
that|UU|1059.87|1059.96|||
are|UU|1059.96|1060.08|||
about|UU|1060.08|1060.41|||
to|UU|1060.41|1060.5|||
start|UU|1060.5|1060.91|||
regarding|UU|1060.92|1061.4|||
the|UU|1061.4|1061.46|||
assessment|UU|1061.47|1061.94|,||
Abrash|UU|1061.94|1062.36|||
should|UU|1062.36|1062.69|||
be|UU|1062.69|1063.2|||
likely|UU|1064.37|1064.85|||
to|UU|1064.85|1065.0|||
work|UU|1065.0|1065.48|||
based|UU|1065.48|1065.99|||
on|UU|1065.99|1066.47|||
the|UU|1066.47|1066.59|||
fact|UU|1066.59|1066.98|||
that|UU|1066.98|1067.13|||
the|UU|1067.13|1067.25|||
mechanism|UU|1067.25|1068.09|||
for|UU|1068.27|1068.44|||
proctology|UU|1068.45|1069.16|||
and|UU|1069.17|1069.29|||
or|UU|1069.29|1069.38|||
other|UU|1069.38|1069.56|||
Rath's|UU|1069.56|1069.89|||
inhibitors|UU|1069.89|1070.43|||
is|UU|1070.79|1071.09|||
the|UU|1071.09|1071.24|||
direct|UU|1071.24|1071.84|||
inhibition|UU|1071.84|1072.59|||
of|UU|1072.75|1073.0|||
these|UU|1073.73|1074.0|||
compounds|UU|1074.0|1074.6|||
by|UU|1074.6|1074.96|||
covalently|UU|1075.11|1076.13|||
to|UU|1076.43|1076.61|||
rap|UU|1076.61|1077.09|.||
So|UU|1077.3|1077.54|||
what|UU|1077.54|1077.72|||
we're|UU|1077.72|1077.87|||
really|UU|1077.87|1078.38|||
measuring|UU|1078.38|1079.1|||
is|UU|1079.37|1079.58|||
a|UU|1079.58|1079.64|||
chemical|UU|1079.64|1080.18|||
reaction|UU|1080.18|1080.99|||
in|UU|1081.92|1082.22|||
vivo|UU|1082.22|1082.76|||
and|UU|1082.76|1082.91|||
in|UU|1082.91|1083.0|||
this|UU|1083.0|1083.21|||
case|UU|1083.21|1083.69|,||
in|UU|1083.69|1084.02|||
the|UU|1084.02|1084.44|||
Attia|UU|1084.56|1085.01|||
fluid|UU|1085.01|1085.46|||
of|UU|1085.46|1085.55|||
patients|UU|1085.55|1086.15|||
that|UU|1086.15|1086.39|||
have|UU|1086.39|1086.57|||
been|UU|1086.57|1086.75|||
administered|UU|1086.75|1087.47|.||
Scilab|UU|1088.55|1089.0|||
in|UU|1090.08|1090.32|||
all|UU|1090.32|1090.48|||
of|UU|1090.48|1090.53|||
that|UU|1090.53|1090.83|||
leads|UU|1090.83|1091.25|||
us|UU|1091.25|1091.55|||
to|UU|1091.55|1091.76|||
believe|UU|1091.76|1092.24|||
that|UU|1092.24|1092.39|||
we'll|UU|1092.39|1092.51|||
be|UU|1092.51|1092.66|||
in|UU|1092.66|1092.75|||
a|UU|1092.75|1092.78|||
position|UU|1092.78|1093.38|||
to|UU|1093.38|1093.77|||
file|UU|1093.77|1094.25|||
an|UU|1094.25|1094.4|||
NDA|UU|1094.4|1094.88|||
for|UU|1094.88|1095.03|||
dry|UU|1095.03|1095.36|||
disease|UU|1095.36|1095.99|||
next|UU|1096.44|1096.83|||
year|UU|1096.83|1097.19|.||
As|UU|1097.19|1097.43|||
we|UU|1097.43|1097.7|||
have|UU|1097.7|1098.24|||
previously|UU|1098.36|1099.02|||
announced|UU|1099.02|1099.62|||
regarding|UU|1101.06|1101.93|||
the|UU|1102.47|1102.68|||
covid|UU|1102.68|1103.19|||
trial|UU|1103.19|1103.61|||
design|UU|1103.61|1104.3|,||
we|UU|1105.59|1105.86|||
anticipate|UU|1105.86|1106.76|||
for|UU|1106.76|1107.06|||
both|UU|1107.06|1107.42|||
programs|UU|1107.42|1108.11|||
enrolling|UU|1108.11|1108.68|||
approximately|UU|1108.68|1109.7|||
30|UU|1110.27|1110.72|||
patients|UU|1110.72|1111.32|.||
I|UU|1111.32|1111.41|||
think|UU|1111.41|1111.65|||
they'll|UU|1111.65|1111.83|||
likely|UU|1111.83|1112.28|||
be|UU|1112.28|1112.43|||
a|UU|1112.43|1112.52|||
two|UU|1112.52|1112.73|||
to|UU|1112.73|1112.85|||
one|UU|1112.85|1113.15|||
randomization|UU|1113.15|1113.9|||
drug|UU|1113.9|1114.29|||
to|UU|1114.29|1114.77|||
placebo|UU|1114.77|1115.7|.||
At|UU|1116.3|1116.51|||
this|UU|1116.51|1116.78|||
point|UU|1116.78|1117.14|,||
we|UU|1117.15|1117.32|||
have|UU|1117.32|1117.56|||
not|UU|1117.56|1118.01|||
included|UU|1118.01|1118.7|||
adaptive|UU|1118.7|1119.36|||
designs|UU|1119.36|1120.11|.||
I|UU|1120.41|1120.62|||
think|UU|1120.62|1120.92|||
the|UU|1120.92|1121.07|||
nature|UU|1121.07|1121.82|||
of|UU|1121.82|1121.97|||
the|UU|1121.97|1122.06|||
results|UU|1122.06|1122.87|||
of|UU|1122.87|1123.14|||
these|UU|1123.17|1123.47|||
first|UU|1123.47|1124.04|||
trials|UU|1124.67|1125.36|||
will|UU|1125.66|1125.87|||
help|UU|1125.87|1126.14|||
us|UU|1126.14|1126.32|||
determine|UU|1126.32|1126.83|||
subsequent|UU|1126.83|1127.43|||
clinical|UU|1127.43|1127.82|||
testing|UU|1127.82|1128.18|,||
which|UU|1128.18|1128.36|||
is|UU|1128.36|1128.48|||
obviously|UU|1128.48|1128.93|||
going|UU|1128.93|1129.14|||
to|UU|1129.14|1129.23|||
be|UU|1129.23|1129.41|||
much|UU|1129.41|1129.71|||
more|UU|1129.71|1130.13|||
significant|UU|1130.7|1131.54|||
if|UU|1132.05|1132.32|||
there|UU|1132.32|1132.47|||
are|UU|1132.47|1132.56|||
positive|UU|1132.56|1133.04|||
results|UU|1133.04|1133.61|||
from|UU|1133.88|1134.12|||
the|UU|1134.12|1134.24|||
preliminary|UU|1134.24|1134.99|||
outputs|UU|1135.41|1136.04|||
that|UU|1136.04|1136.19|||
we|UU|1136.19|1136.34|||
have|UU|1136.34|1136.61|||
here|UU|1136.61|1137.05|.||
Enrollment|UU|1138.11|1138.74|||
hasn't|UU|1138.74|1139.1|||
started|UU|1139.1|1139.64|||
the|UU|1139.64|1139.76|||
eye|UU|1139.76|1139.97|||
and|UU|1139.97|1140.3|||
has|UU|1140.3|1140.45|||
been|UU|1140.45|1140.63|||
filed|UU|1140.63|1140.96|||
for|UU|1140.96|1141.11|||
six|UU|1141.11|1141.41|||
to|UU|1141.41|1141.56|||
nine|UU|1141.56|1141.89|.||
As|UU|1141.89|1142.04|||
I|UU|1142.04|1142.16|||
mentioned|UU|1142.16|1142.52|||
on|UU|1142.52|1142.64|||
the|UU|1142.64|1142.73|||
call|UU|1142.73|1143.06|||
today|UU|1143.06|1143.6|,||
16|UU|1144.11|1144.71|||
12|UU|1144.71|1145.31|||
is|UU|1145.52|1145.76|||
the|UU|1145.76|1145.88|||
subject|UU|1145.88|1146.42|||
of|UU|1146.42|1146.9|||
further|UU|1147.14|1147.83|||
InVivo|UU|1148.61|1149.39|||
investigation|UU|1149.39|1150.44|||
included|UU|1151.88|1152.72|||
that|UU|1152.99|1153.38|||
is|UU|1153.38|1153.65|||
being|UU|1153.65|1153.92|||
performed|UU|1153.92|1154.76|||
by|UU|1155.09|1155.48|||
Naiad|UU|1155.48|1156.2|.||
And|UU|1156.2|1156.38|||
we're|UU|1156.38|1156.53|||
absolutely|UU|1156.53|1157.31|||
thrilled|UU|1157.31|1157.91|||
about|UU|1158.21|1158.72|||
Naiades|UU|1158.72|1159.35|||
decision|UU|1159.35|1160.01|||
to|UU|1160.01|1160.52|||
to|UU|1160.85|1160.99|||
test|UU|1161.09|1161.69|||
ATX|UU|1161.84|1162.25|||
16|UU|1162.32|1162.73|||
12|UU|1162.74|1163.22|||
on|UU|1163.61|1163.88|||
our|UU|1163.88|1164.03|||
behalf|UU|1164.03|1164.51|.||
The|UU|1166.61|1166.76|||
covid|UU|1166.76|1167.09|||
impact|UU|1167.09|1167.63|,||
as|UU|1167.84|1168.02|||
you|UU|1168.02|1168.2|||
mentioned|UU|1168.2|1168.8|,||
with|UU|1168.8|1169.28|||
across|UU|1169.31|1169.76|||
the|UU|1169.76|1169.88|||
industry|UU|1169.88|1170.27|||
has|UU|1170.27|1170.42|||
been|UU|1170.42|1170.57|||
significant|UU|1170.57|1171.38|.||
The|UU|1172.22|1172.58|||
one|UU|1172.58|1173.12|||
trial|UU|1173.12|1173.78|||
in|UU|1173.99|1174.29|||
our|UU|1174.29|1174.62|||
case|UU|1174.62|1175.01|||
and|UU|1175.01|1175.1|||
our|UU|1175.1|1175.22|||
pipeline|UU|1175.22|1175.76|||
that|UU|1175.76|1175.88|||
has|UU|1175.88|1176.0|||
been|UU|1176.0|1176.18|||
affected|UU|1176.18|1176.78|||
by|UU|1177.47|1177.83|||
covid-19|UU|1177.83|1179.09|||
as|UU|1179.87|1180.29|||
the|UU|1180.29|1180.53|||
guard|UU|1180.53|1180.89|||
trial|UU|1180.89|1181.31|,||
the|UU|1181.31|1181.43|||
phase|UU|1181.43|1181.79|||
three|UU|1181.79|1182.03|||
trial|UU|1182.27|1182.63|||
for|UU|1182.63|1182.83|||
PDR|UU|1182.83|1183.56|,||
what|UU|1184.49|1184.91|||
seemed|UU|1184.91|1185.39|||
to|UU|1185.39|1185.69|||
have|UU|1185.69|1185.93|||
happened|UU|1185.93|1186.62|||
during|UU|1186.8|1187.46|||
the|UU|1187.97|1188.15|||
peak|UU|1188.15|1188.57|||
of|UU|1188.78|1189.44|||
covid|UU|1190.49|1191.03|||
cases|UU|1191.03|1191.66|||
back|UU|1192.26|1192.56|||
in|UU|1192.56|1192.62|||
March|UU|1192.62|1192.98|,||
April|UU|1192.98|1193.4|,||
May|UU|1193.4|1193.73|||
and|UU|1193.73|1193.85|||
so|UU|1193.85|1194.03|||
forth|UU|1194.03|1194.42|||
was|UU|1194.75|1195.08|||
that|UU|1195.08|1195.23|||
many|UU|1195.23|1195.53|||
patients|UU|1195.53|1196.04|||
simply|UU|1196.04|1196.43|||
were|UU|1196.43|1196.61|||
not|UU|1196.61|1196.94|||
coming|UU|1196.94|1197.27|||
into|UU|1197.27|1197.48|||
the|UU|1197.48|1197.6|||
hospital|UU|1197.6|1198.2|||
despite|UU|1198.2|1198.92|||
vision|UU|1200.57|1200.96|||
changes|UU|1200.96|1201.47|,||
despite|UU|1201.47|1202.13|||
losing|UU|1202.61|1203.09|||
sight|UU|1203.09|1203.57|||
of|UU|1204.12|1204.17|||
the|UU|1204.41|1205.01|||
number|UU|1206.27|1206.75|||
of|UU|1207.02|1207.29|||
patients|UU|1207.29|1207.77|||
coming|UU|1207.77|1208.13|||
in|UU|1208.13|1208.52|||
was|UU|1209.3|1209.78|||
diminished|UU|1209.78|1210.41|||
during|UU|1211.07|1211.43|||
that|UU|1211.43|1211.64|||
time|UU|1211.64|1211.97|||
frame|UU|1211.97|1212.42|.||
And|UU|1212.81|1213.08|||
furthermore|UU|1213.08|1213.98|,||
many|UU|1214.16|1214.52|||
clinical|UU|1214.52|1215.0|||
sites|UU|1215.0|1215.51|,||
as|UU|1215.51|1215.6|||
you|UU|1215.6|1215.72|||
know|UU|1215.72|1216.17|,||
simply|UU|1216.17|1216.65|||
did|UU|1216.65|1216.8|||
not|UU|1216.8|1217.07|||
have|UU|1217.07|1217.52|||
research|UU|1217.52|1218.06|||
staff|UU|1218.06|1218.57|||
which|UU|1219.29|1219.5|||
were|UU|1219.5|1219.62|||
considered|UU|1219.62|1220.16|||
for|UU|1220.16|1220.34|||
a|UU|1220.34|1220.43|||
while|UU|1220.43|1220.73|||
to|UU|1220.73|1220.82|||
be|UU|1220.82|1220.94|||
non|UU|1220.94|1221.18|||
essential|UU|1221.18|1221.72|,||
such|UU|1222.47|1222.8|||
that|UU|1222.8|1222.98|||
it|UU|1222.98|1223.07|||
was|UU|1223.07|1223.34|||
difficult|UU|1223.76|1224.27|,||
if|UU|1224.27|1224.48|||
not|UU|1224.48|1224.72|||
impossible|UU|1224.72|1225.41|||
in|UU|1225.41|1225.53|||
some|UU|1225.53|1225.77|||
cases|UU|1225.77|1226.31|,||
to|UU|1226.91|1227.09|||
enroll|UU|1227.09|1227.51|||
to|UU|1227.6|1227.81|||
enroll|UU|1227.81|1228.08|||
patients|UU|1228.08|1228.65|.||
However|UU|1229.4|1230.24|,||
the|UU|1230.6|1230.72|||
good|UU|1230.72|1230.87|||
news|UU|1230.87|1231.14|||
is|UU|1231.14|1231.5|||
regarding|UU|1231.5|1231.92|||
the|UU|1231.92|1232.01|||
rest|UU|1232.01|1232.22|||
of|UU|1232.22|1232.28|||
the|UU|1232.28|1232.37|||
pipeline|UU|1232.37|1233.12|.||
We|UU|1233.15|1233.51|||
do|UU|1233.51|1233.75|||
not|UU|1233.75|1233.99|||
seem|UU|1233.99|1234.35|||
to|UU|1234.35|1234.5|||
be|UU|1234.5|1234.95|||
have|UU|1234.98|1235.18|||
been|UU|1235.19|1235.41|||
overtly|UU|1235.79|1236.33|||
affected|UU|1236.33|1236.93|||
by|UU|1237.32|1237.56|||
covid|UU|1237.56|1237.95|||
in|UU|1237.95|1238.07|||
terms|UU|1238.07|1238.4|||
of|UU|1238.4|1238.52|||
enrollment|UU|1238.52|1239.09|.||
The|UU|1239.84|1239.96|||
dry|UU|1239.96|1240.29|||
program|UU|1240.38|1241.07|||
was|UU|1241.07|1241.58|||
largely|UU|1241.58|1242.51|||
under|UU|1242.87|1243.14|||
discussion|UU|1243.14|1243.65|||
with|UU|1243.65|1243.8|||
the|UU|1243.8|1243.89|||
FDA|UU|1243.89|1244.58|||
during|UU|1245.18|1245.57|||
the|UU|1245.57|1245.69|||
peak|UU|1245.69|1245.96|||
number|UU|1245.96|1246.26|||
of|UU|1246.26|1246.38|||
cases|UU|1246.38|1246.98|||
in|UU|1248.18|1248.36|||
the|UU|1248.36|1248.45|||
spring|UU|1248.45|1248.99|.||
The|UU|1249.83|1250.07|||
Allergy|UU|1250.07|1250.64|||
Program|UU|1250.64|1251.15|||
to|UU|1251.15|1251.24|||
Face|UU|1251.24|1251.59|||
Reality|UU|1251.6|1252.14|||
program|UU|1252.14|1252.86|||
was|UU|1253.55|1253.85|||
on|UU|1253.85|1254.27|||
planned|UU|1254.48|1254.93|||
hold|UU|1255.08|1255.59|||
because|UU|1255.59|1256.22|||
of|UU|1256.22|1256.43|||
pollen|UU|1256.43|1257.0|.||
As|UU|1257.18|1257.39|||
you|UU|1257.39|1257.51|||
know|UU|1257.51|1257.72|,||
you|UU|1257.72|1257.87|||
cannot|UU|1257.87|1258.25|||
enroll|UU|1258.29|1258.74|||
allergy|UU|1258.74|1259.22|||
programs|UU|1259.22|1259.85|||
with|UU|1259.85|1260.03|||
Andrian|UU|1260.03|1260.45|||
Pollen|UU|1260.45|1261.02|||
and|UU|1261.29|1261.56|||
we|UU|1261.56|1261.71|||
expect|UU|1261.71|1262.23|||
any|UU|1262.25|1262.42|||
degree|UU|1262.43|1262.81|||
program|UU|1262.82|1263.42|||
to|UU|1263.42|1263.87|||
reinitiate|UU|1264.41|1265.07|||
again|UU|1265.07|1265.46|||
in|UU|1265.46|1265.61|||
the|UU|1265.61|1265.73|||
fall|UU|1265.73|1266.24|.||
So|UU|1266.42|1266.66|||
we|UU|1266.66|1266.84|||
were|UU|1266.84|1267.08|||
quite|UU|1267.08|1267.38|||
fortunate|UU|1267.38|1267.98|||
in|UU|1267.98|1268.07|||
terms|UU|1268.07|1268.4|||
of|UU|1268.4|1268.49|||
timing|UU|1268.49|1269.0|||
with|UU|1269.0|1269.18|||
regard|UU|1269.18|1269.57|||
to|UU|1269.57|1269.78|||
our|UU|1269.78|1269.93|||
other|UU|1269.93|1270.35|||
clinical|UU|1270.8|1271.19|||
programs|UU|1271.19|1271.67|.||
We|UU|1271.67|1272.12|||
relative|UU|1273.14|1273.8|||
to|UU|1273.8|1273.98|||
the|UU|1273.98|1274.1|||
impact|UU|1274.1|1274.58|||
of|UU|1274.58|1274.88|||
of|UU|1274.88|1275.12|||
covid|UU|1275.12|1275.57|.||
OK|UU|1277.74|1278.14|,||
thank|UU|1278.19|1278.55|||
you|UU|1278.55|1278.91|.||
As|UU|1280.85|1281.21|||
a|UU|1281.21|1281.24|||
reminder|UU|1281.24|1281.78|,||
if|UU|1281.78|1281.87|||
you|UU|1281.87|1281.96|||
would|UU|1281.96|1282.08|||
like|UU|1282.08|1282.23|||
to|UU|1282.23|1282.38|||
ask|UU|1282.38|1282.71|||
a|UU|1282.71|1282.74|||
question|UU|1282.74|1283.22|,||
please|UU|1283.22|1283.55|||
press|UU|1283.55|1283.85|||
star|UU|1283.85|1284.27|,||
then|UU|1284.27|1284.45|||
the|UU|1284.45|1284.54|||
number|UU|1284.54|1284.84|||
one|UU|1284.84|1285.11|||
on|UU|1285.11|1285.32|||
your|UU|1285.32|1285.47|||
telephone|UU|1285.47|1285.92|||
keypad|UU|1285.92|1286.52|,||
that|UU|1286.67|1286.88|||
is|UU|1286.88|1287.0|||
star|UU|1287.0|1287.36|||
one|UU|1287.36|1287.6|||
to|UU|1287.6|1287.72|||
ask|UU|1287.72|1288.05|||
a|UU|1288.05|1288.11|||
question|UU|1288.11|1288.71|.||
Your|UU|1288.95|1289.13|||
next|UU|1289.13|1289.49|||
question|UU|1289.49|1289.94|||
comes|UU|1289.94|1290.21|||
from|UU|1290.21|1290.36|||
the|UU|1290.36|1290.45|||
line|UU|1290.45|1290.78|||
of|UU|1290.78|1290.9|||
Justin|UU|1290.9|1291.32|||
with|UU|1291.62|1291.8|||
Oppenheimer|UU|1291.8|1292.46|||
and|UU|1292.46|1292.61|||
Company|UU|1292.61|1293.15|.||
Hi|UU|1295.03|1295.36|,||
good|UU|1295.36|1295.48|||
morning|UU|1295.48|1295.72|,||
guys|UU|1295.72|1295.99|,||
thanks|UU|1295.99|1296.2|||
for|UU|1296.2|1296.26|||
taking|UU|1296.26|1296.47|||
my|UU|1296.47|1296.53|||
questions|UU|1296.53|1296.95|||
and|UU|1296.95|1297.07|||
congrats|UU|1297.07|1297.43|||
on|UU|1297.43|1297.49|||
the|UU|1297.49|1297.58|||
progress|UU|1297.58|1298.06|.||
I|UU|1299.11|1299.29|||
know|UU|1299.29|1299.41|||
it's|UU|1299.41|1299.62|||
early|UU|1299.62|1299.92|||
days|UU|1299.92|1300.31|,||
but|UU|1300.31|1300.64|,||
you|UU|1300.85|1301.03|||
know|UU|1301.03|1301.1|,||
as|UU|1301.15|1301.27|||
you|UU|1301.27|1301.39|||
think|UU|1301.39|1301.6|||
about|UU|1301.6|1301.81|||
establishing|UU|1301.81|1302.47|||
a|UU|1302.47|1302.5|||
class|UU|1302.74|1303.07|||
action|UU|1303.07|1303.4|||
on|UU|1303.4|1303.52|||
race|UU|1303.52|1303.88|,||
this|UU|1303.97|1304.15|||
kind|UU|1304.15|1304.36|||
of|UU|1304.36|1304.42|||
dry|UU|1304.42|1304.77|||
eye|UU|1304.77|1305.02|,||
we've|UU|1305.38|1305.59|||
had|UU|1305.59|1305.71|||
some|UU|1305.71|1305.86|||
discussion|UU|1305.86|1306.25|||
with|UU|1306.25|1306.37|||
investors|UU|1306.37|1306.76|||
on|UU|1306.76|1306.88|||
what|UU|1306.88|1307.09|||
would|UU|1307.09|1307.27|||
be|UU|1307.27|1307.54|||
an|UU|1307.54|1307.63|||
appropriate|UU|1307.63|1308.11|||
duration|UU|1308.11|1308.59|||
of|UU|1308.59|1308.71|||
observations|UU|1308.71|1309.4|||
of|UU|1309.4|1309.5|||
that|UU|1309.53|1309.68|||
activity|UU|1309.91|1310.51|.||
Can|UU|1310.81|1310.96|||
you|UU|1310.96|1311.02|||
just|UU|1311.02|1311.2|||
talk|UU|1311.2|1311.41|||
a|UU|1311.41|1311.5|||
little|UU|1311.5|1311.71|||
bit|UU|1311.71|1311.86|||
about|UU|1311.86|1312.1|||
the|UU|1312.1|1312.19|||
rationale|UU|1312.19|1312.61|||
behind|UU|1312.61|1313.0|||
the|UU|1313.0|1313.09|||
acute|UU|1313.09|1313.57|||
versus|UU|1313.57|1313.99|||
four|UU|1313.99|1314.23|||
week|UU|1314.23|1314.41|||
time|UU|1314.41|1314.71|||
points|UU|1314.71|1315.19|||
from|UU|1315.19|1315.37|||
a|UU|1315.37|1315.43|||
trial|UU|1315.43|1315.72|||
perspective|UU|1315.74|1316.6|,||
disease|UU|1317.17|1317.65|||
perspective|UU|1317.65|1318.25|||
and|UU|1318.25|1318.37|||
labeling|UU|1318.4|1318.7|||
perspective|UU|1318.73|1319.36|?||
Good|UU|1322.27|1322.42|||
morning|UU|1322.42|1322.69|,||
Justin|UU|1322.69|1323.26|.||
And|UU|1324.16|1324.39|||
good|UU|1324.4|1324.55|||
to|UU|1324.55|1324.64|||
hear|UU|1324.64|1324.85|||
from|UU|1324.85|1325.06|||
you|UU|1325.06|1325.26|,||
the|UU|1326.59|1327.31|||
as|UU|1327.79|1328.03|||
I|UU|1328.03|1328.21|||
highlighted|UU|1328.24|1328.78|||
in|UU|1328.78|1328.87|||
my|UU|1328.87|1329.05|||
comments|UU|1329.05|1329.77|||
this|UU|1330.07|1330.37|||
morning|UU|1330.37|1330.79|,||
the|UU|1330.79|1330.97|||
potential|UU|1330.97|1331.57|||
range|UU|1331.57|1332.11|||
of|UU|1332.11|1332.26|||
dosing|UU|1332.26|1332.68|||
duration|UU|1332.68|1333.31|||
for|UU|1333.31|1333.49|||
the|UU|1333.49|1333.55|||
rest|UU|1333.55|1333.92|||
trials|UU|1333.94|1334.48|||
is|UU|1334.78|1335.02|||
anywhere|UU|1335.02|1335.35|||
from|UU|1335.35|1335.53|||
one|UU|1335.53|1335.77|||
to|UU|1335.77|1335.89|||
two|UU|1335.89|1336.13|||
days|UU|1336.13|1336.49|||
on|UU|1336.49|1336.61|||
the|UU|1336.61|1336.73|||
acute|UU|1336.73|1337.12|||
end|UU|1337.12|1337.45|||
to|UU|1337.84|1338.17|||
28|UU|1338.17|1338.71|||
days|UU|1338.71|1339.22|||
on|UU|1339.52|1339.79|||
the|UU|1339.79|1339.85|||
more|UU|1339.85|1340.24|||
chronic|UU|1340.57|1341.02|||
or|UU|1341.02|1341.11|||
sub|UU|1341.11|1341.34|||
chronic|UU|1341.35|1341.77|||
end|UU|1341.77|1342.01|,||
which|UU|1342.01|1342.22|||
reflects|UU|1342.22|1342.82|||
the|UU|1342.82|1342.94|||
phase|UU|1342.96|1343.3|||
to|UU|1343.3|1343.54|||
a|UU|1343.54|1343.75|||
trial|UU|1343.75|1344.23|.||
That|UU|1344.32|1344.59|||
is|UU|1344.59|1344.77|||
the|UU|1344.77|1344.89|||
data|UU|1344.89|1345.22|||
in|UU|1345.22|1345.34|||
our|UU|1345.34|1345.43|||
corporate|UU|1345.43|1345.85|||
deck|UU|1345.85|1346.12|||
showing|UU|1346.12|1346.45|||
that|UU|1346.45|1346.6|||
after|UU|1346.6|1346.84|||
28|UU|1346.84|1347.29|||
days|UU|1347.29|1347.56|||
of|UU|1347.56|1347.65|||
administration|UU|1347.65|1348.37|||
of|UU|1348.37|1348.49|||
approx|UU|1348.49|1348.81|||
lab|UU|1348.93|1349.29|,||
there|UU|1349.75|1349.89|||
was|UU|1349.9|1350.05|||
a|UU|1350.05|1350.11|||
highly|UU|1350.11|1350.5|||
statistically|UU|1350.5|1351.19|||
significant|UU|1351.19|1351.82|||
reduction|UU|1352.09|1352.87|||
in|UU|1353.02|1353.29|||
raths|UU|1353.29|1353.74|||
levels|UU|1353.74|1354.25|,||
as|UU|1354.25|1354.43|||
measured|UU|1354.43|1354.82|||
by|UU|1354.82|1355.09|||
Alysa|UU|1355.09|1355.76|.||
I|UU|1356.71|1356.92|||
want|UU|1356.92|1357.1|||
to|UU|1357.1|1357.16|||
spend|UU|1357.16|1357.46|||
a|UU|1357.46|1357.55|||
few|UU|1357.55|1357.88|||
seconds|UU|1357.88|1358.39|||
talking|UU|1358.39|1358.81|||
about|UU|1358.81|1359.14|||
the|UU|1359.14|1359.29|||
two|UU|1359.29|1359.53|||
different|UU|1359.53|1359.89|||
ways|UU|1359.89|1360.34|||
to|UU|1360.34|1360.49|||
measure|UU|1360.49|1361.15|||
Ra|UU|1361.51|1362.02|||
Ra|UU|1362.49|1362.84|||
exist|UU|1363.31|1363.85|||
in|UU|1363.85|1364.0|||
our|UU|1364.0|1364.12|||
body|UU|1364.12|1364.54|||
and|UU|1364.54|1364.66|||
to|UU|1364.66|1364.87|||
form|UU|1364.87|1365.29|||
so-called|UU|1365.29|1365.8|||
free|UU|1365.8|1366.1|||
Raafat|UU|1366.1|1366.7|||
of|UU|1366.76|1366.88|||
rap|UU|1367.06|1367.51|||
that|UU|1367.51|1367.63|||
are|UU|1367.63|1367.72|||
sort|UU|1367.72|1367.96|||
of|UU|1367.96|1368.02|||
floating|UU|1368.02|1368.38|||
around|UU|1368.38|1368.77|||
and|UU|1368.77|1368.95|||
in|UU|1368.95|1369.07|||
rats|UU|1369.07|1369.43|||
that|UU|1369.43|1369.61|||
are|UU|1369.61|1369.7|||
bound|UU|1369.7|1370.15|||
to|UU|1370.15|1370.3|||
produce|UU|1370.3|1370.99|||
the|UU|1372.1|1372.28|||
Alysa|UU|1372.28|1373.21|||
measures|UU|1373.24|1373.87|||
rats|UU|1373.87|1374.32|||
found|UU|1374.32|1374.68|||
of|UU|1374.68|1374.74|||
proteins|UU|1374.74|1375.38|.||
And|UU|1375.7|1376.06|||
as|UU|1376.06|1376.3|||
you|UU|1376.3|1376.39|||
know|UU|1376.39|1376.81|,||
Alize|UU|1376.81|1377.25|||
is|UU|1377.26|1377.41|||
an|UU|1377.41|1377.53|||
antibody|UU|1377.53|1378.22|||
mediated|UU|1378.22|1378.94|||
detection|UU|1379.6|1380.32|||
assay|UU|1380.32|1380.99|.||
The|UU|1381.25|1381.46|||
reason|UU|1381.46|1382.09|||
why|UU|1382.09|1382.66|||
we're|UU|1382.66|1382.84|||
able|UU|1382.84|1383.14|||
to|UU|1383.14|1383.23|||
generate|UU|1383.23|1383.68|||
antibodies|UU|1383.68|1384.55|||
to|UU|1384.76|1385.06|||
our|UU|1385.06|1385.35|||
grasp|UU|1385.36|1385.99|||
is|UU|1385.99|1386.14|||
that|UU|1386.14|1386.29|||
when|UU|1386.29|1386.47|||
rats|UU|1386.47|1386.83|||
find|UU|1386.83|1387.15|||
the|UU|1387.15|1387.19|||
proteins|UU|1387.19|1387.71|,||
their|UU|1387.73|1387.91|||
antigen|UU|1387.91|1388.6|||
and|UU|1389.44|1390.1|||
form|UU|1390.37|1390.85|||
antibodies|UU|1390.85|1391.6|,||
in|UU|1391.6|1391.72|||
some|UU|1391.72|1391.96|||
cases|UU|1391.96|1392.53|||
antibodies|UU|1393.13|1393.85|||
against|UU|1393.85|1394.18|||
self|UU|1394.18|1394.51|||
protein|UU|1394.51|1395.07|.||
So|UU|1395.53|1395.74|||
the|UU|1395.74|1395.86|||
allies|UU|1395.86|1396.31|||
on|UU|1396.31|1396.46|||
measures|UU|1396.46|1396.91|||
found|UU|1396.91|1397.33|||
rats|UU|1397.33|1397.8|||
and|UU|1397.81|1398.02|||
found|UU|1398.02|1398.41|||
rats|UU|1398.41|1398.8|||
generally|UU|1398.8|1399.52|||
accumulate|UU|1399.52|1400.24|||
over|UU|1400.24|1400.57|||
time|UU|1400.57|1401.11|.||
Which|UU|1401.59|1401.83|||
is|UU|1401.83|1401.98|||
why|UU|1401.98|1402.28|||
in|UU|1402.28|1402.37|||
the|UU|1402.37|1402.43|||
phase|UU|1402.43|1402.76|||
two|UU|1402.76|1402.91|,||
a|UU|1402.91|1403.02|||
study|UU|1403.03|1403.33|||
over|UU|1403.33|1403.54|||
twenty|UU|1403.54|1403.84|||
eight|UU|1403.84|1403.96|||
days|UU|1403.96|1404.23|,||
we|UU|1404.23|1404.35|||
use|UU|1404.35|1404.59|||
the|UU|1404.59|1404.71|||
Allies|UU|1404.71|1405.16|||
to|UU|1405.25|1405.43|||
assess|UU|1405.43|1405.94|||
Roswell's|UU|1406.24|1407.1|||
on|UU|1407.71|1407.92|||
the|UU|1407.92|1408.04|||
other|UU|1408.04|1408.25|||
end|UU|1408.25|1408.4|||
of|UU|1408.4|1408.46|||
the|UU|1408.46|1408.55|||
spectrum|UU|1408.55|1409.24|||
regarding|UU|1409.91|1410.47|||
one|UU|1410.47|1410.74|||
to|UU|1410.74|1410.83|||
two|UU|1410.83|1411.13|||
day|UU|1411.13|1411.43|||
or|UU|1411.43|1411.58|||
acute|UU|1411.58|1412.09|||
dosing|UU|1412.09|1412.72|||
for|UU|1412.96|1413.11|||
Scilab|UU|1413.43|1413.9|.||
We|UU|1414.46|1414.7|||
think|UU|1414.7|1415.0|||
that|UU|1415.0|1415.45|||
techniques|UU|1415.69|1416.23|||
such|UU|1416.23|1416.5|||
as|UU|1416.5|1416.65|||
LCN|UU|1416.65|1417.34|||
Masback|UU|1417.4|1418.12|||
might|UU|1418.45|1418.87|||
be|UU|1418.87|1419.44|||
more|UU|1419.74|1420.04|||
relevant|UU|1420.04|1420.61|||
to|UU|1420.61|1420.82|||
assessing|UU|1420.82|1421.33|||
rats|UU|1421.33|1421.72|||
because|UU|1421.72|1422.17|||
there|UU|1422.17|1422.62|||
we'd|UU|1422.62|1422.77|||
be|UU|1422.77|1422.92|||
looking|UU|1422.92|1423.28|||
at|UU|1423.28|1423.37|||
prerace|UU|1423.37|1424.01|||
levels|UU|1424.03|1424.48|||
that|UU|1424.48|1424.63|||
would|UU|1424.63|1424.75|||
change|UU|1424.75|1425.08|||
acutely|UU|1425.08|1425.83|||
following|UU|1426.46|1427.09|||
dosing|UU|1427.09|1427.62|.||
So|UU|1428.05|1428.5|||
somewhere|UU|1428.68|1429.37|||
within|UU|1429.37|1429.85|||
those|UU|1429.85|1430.36|||
two|UU|1430.36|1430.69|||
ranges|UU|1430.69|1431.5|||
of|UU|1431.53|1432.04|||
dosing|UU|1432.04|1432.55|||
paradigms|UU|1432.55|1433.33|||
and|UU|1433.57|1433.81|||
those|UU|1433.81|1434.23|||
two|UU|1434.23|1434.56|||
different|UU|1434.56|1435.04|||
assay|UU|1435.04|1435.49|||
techniques|UU|1435.49|1436.24|,||
we|UU|1437.14|1437.41|||
will|UU|1437.41|1437.59|||
end|UU|1437.59|1437.77|||
up|UU|1437.77|1437.92|||
validating|UU|1437.92|1438.82|||
the|UU|1439.21|1439.39|||
precise|UU|1439.39|1439.99|||
technique|UU|1439.99|1440.65|||
and|UU|1440.65|1440.86|||
and|UU|1441.01|1441.52|||
then|UU|1441.97|1442.45|||
establishing|UU|1442.78|1443.47|||
protocol|UU|1443.47|1443.95|||
designed|UU|1443.96|1444.55|||
for|UU|1445.39|1445.75|||
the|UU|1445.75|1446.08|||
first|UU|1446.38|1446.8|||
of|UU|1446.8|1446.86|||
the|UU|1446.86|1446.95|||
rat|UU|1446.95|1447.19|||
studies|UU|1447.2|1447.67|||
to|UU|1447.67|1447.82|||
begin|UU|1447.82|1448.12|||
shortly|UU|1448.12|1448.63|.||
OK|UU|1450.25|1450.61|,||
great|UU|1450.61|1450.87|.||
Got|UU|1450.91|1451.15|||
it|UU|1451.15|1451.27|.||
And|UU|1452.26|1452.44|||
maybe|UU|1452.5|1452.79|||
then|UU|1452.8|1453.23|,||
you|UU|1453.52|1453.67|||
know|UU|1453.7|1453.96|,||
how|UU|1454.78|1454.99|||
do|UU|1454.99|1455.08|||
you|UU|1455.08|1455.14|||
think|UU|1455.14|1455.38|||
about|UU|1455.38|1455.62|||
dosing|UU|1455.62|1456.16|||
regimens|UU|1456.16|1456.64|||
to|UU|1456.64|1456.77|||
be|UU|1456.77|1456.85|||
investigated|UU|1456.85|1457.39|?||
Have|UU|1457.51|1457.6|||
you|UU|1457.6|1457.69|||
had|UU|1457.69|1457.84|||
conversations|UU|1457.84|1458.56|||
with|UU|1458.56|1458.71|||
the|UU|1458.71|1458.8|||
FDA|UU|1458.8|1459.28|||
on|UU|1459.28|1459.48|,||
you|UU|1459.79|1459.97|||
know|UU|1459.97|1460.02|,||
whether|UU|1460.09|1460.42|||
you'd|UU|1460.42|1460.6|||
have|UU|1460.6|1460.78|||
to|UU|1460.78|1460.9|||
do|UU|1460.9|1461.23|||
sort|UU|1461.23|1461.47|||
of|UU|1461.47|1461.77|||
kidi|UU|1462.1|1462.94|||
or|UU|1462.94|1463.24|||
the|UU|1463.27|1463.47|||
idea|UU|1463.48|1464.0|,||
you|UU|1464.02|1464.17|||
know|UU|1464.17|1464.29|,||
just|UU|1464.29|1464.5|||
to|UU|1464.5|1464.59|||
appreciate|UU|1464.59|1465.1|||
that|UU|1465.1|1465.31|||
you|UU|1465.31|1465.46|||
would|UU|1465.46|1465.76|||
be|UU|1465.76|1465.98|||
tapering|UU|1465.98|1466.66|||
and|UU|1466.66|1467.2|||
sort|UU|1467.2|1467.41|||
of|UU|1467.41|1467.65|||
disease|UU|1468.61|1469.03|||
state|UU|1469.03|1469.48|||
eventually|UU|1470.02|1470.74|?||
Right|UU|1472.63|1473.1|,||
and|UU|1473.11|1473.53|||
that|UU|1473.53|1473.68|||
gets|UU|1473.68|1473.92|||
back|UU|1473.92|1474.1|||
to|UU|1474.1|1474.22|||
the|UU|1474.22|1474.31|||
first|UU|1474.31|1474.55|||
part|UU|1474.55|1474.73|||
of|UU|1474.73|1474.79|||
your|UU|1474.79|1474.94|||
question|UU|1474.94|1475.48|,||
how|UU|1475.48|1476.05|||
might|UU|1476.38|1476.68|||
the|UU|1476.68|1476.77|||
clinical|UU|1476.77|1477.19|||
community|UU|1477.19|1477.73|||
perceive|UU|1477.73|1478.39|||
duration|UU|1478.99|1479.5|||
of|UU|1479.5|1479.59|||
dosing|UU|1479.59|1480.04|||
and|UU|1480.04|1480.13|||
dosing|UU|1480.13|1480.64|||
regimen|UU|1480.91|1481.54|?||
First|UU|1482.53|1482.92|||
of|UU|1482.92|1483.01|||
all|UU|1483.01|1483.28|,||
I|UU|1483.31|1483.52|||
think|UU|1483.52|1483.91|||
that|UU|1483.91|1484.48|||
signs|UU|1485.5|1486.34|||
of|UU|1486.34|1486.76|||
diseases|UU|1486.76|1487.6|,||
including|UU|1487.6|1488.17|||
dry|UU|1488.17|1488.38|||
eye|UU|1488.38|1488.5|||
disease|UU|1488.5|1489.04|,||
are|UU|1489.79|1490.3|||
primarily|UU|1490.36|1491.35|||
or|UU|1491.35|1491.56|||
first|UU|1491.56|1491.92|||
and|UU|1491.92|1492.07|||
foremost|UU|1492.07|1492.91|||
regulatory|UU|1493.21|1494.38|||
milestones|UU|1494.62|1495.35|.||
I|UU|1496.24|1496.45|||
do|UU|1496.45|1496.69|||
not|UU|1496.69|1496.96|||
believe|UU|1496.96|1497.44|||
that|UU|1497.44|1497.61|||
certainly|UU|1497.62|1498.04|||
in|UU|1498.04|1498.16|||
the|UU|1498.16|1498.22|||
case|UU|1498.22|1498.64|||
of|UU|1498.64|1498.76|||
dry|UU|1498.76|1499.0|||
eye|UU|1499.0|1499.06|||
disease|UU|1499.06|1499.57|,||
that|UU|1499.57|1499.78|||
either|UU|1499.78|1500.17|||
physicians|UU|1500.17|1500.92|||
or|UU|1500.92|1501.16|||
patients|UU|1501.16|1501.91|||
are|UU|1502.45|1502.72|||
particularly|UU|1502.72|1503.59|||
worried|UU|1503.59|1504.04|||
about|UU|1504.04|1504.4|||
signs|UU|1504.4|1504.91|.||
Patients|UU|1505.48|1506.05|||
do|UU|1506.05|1506.26|||
not|UU|1506.26|1506.65|||
wake|UU|1506.65|1507.01|||
up|UU|1507.01|1507.22|||
in|UU|1507.22|1507.31|||
the|UU|1507.31|1507.4|||
morning|UU|1507.4|1507.94|||
thinking|UU|1507.94|1508.57|,||
I|UU|1508.87|1509.11|||
wonder|UU|1509.11|1509.41|||
what|UU|1509.41|1509.56|||
my|UU|1509.56|1509.74|||
Shermer|UU|1509.74|1510.05|||
test|UU|1510.07|1510.46|||
is|UU|1510.46|1510.76|.||
I|UU|1511.06|1511.3|||
wonder|UU|1511.3|1511.6|||
what|UU|1511.6|1511.75|||
my|UU|1511.75|1511.9|||
corneal|UU|1511.9|1512.38|||
stain|UU|1512.38|1512.8|||
is|UU|1512.8|1513.13|||
and|UU|1513.4|1513.64|||
so|UU|1513.64|1513.88|||
forth|UU|1513.88|1514.26|.||
Instead|UU|1514.84|1515.53|,||
we've|UU|1515.53|1515.89|||
used|UU|1515.89|1516.16|||
signs|UU|1516.16|1516.64|||
and|UU|1516.64|1516.73|||
I|UU|1516.73|1516.82|||
think|UU|1516.82|1517.01|||
most|UU|1517.01|1517.27|||
patients|UU|1517.27|1517.69|||
and|UU|1517.69|1517.81|||
physicians|UU|1517.81|1518.29|,||
these|UU|1518.29|1518.47|||
scientists|UU|1518.49|1519.01|||
regulatory|UU|1519.04|1520.03|||
milestones|UU|1521.35|1522.19|.||
So|UU|1522.49|1522.82|||
the|UU|1522.82|1523.0|||
dosing|UU|1523.0|1523.63|||
paradigm|UU|1523.63|1524.38|||
for|UU|1524.38|1524.59|||
trials|UU|1524.59|1525.13|||
associated|UU|1525.13|1525.85|||
purely|UU|1525.85|1526.39|||
with|UU|1526.39|1526.54|||
science|UU|1526.54|1527.02|,||
I|UU|1527.02|1527.08|||
think|UU|1527.08|1527.32|||
is|UU|1527.32|1527.44|||
a|UU|1527.44|1527.5|||
lot|UU|1527.5|1527.71|||
less|UU|1527.71|1527.95|||
important|UU|1527.95|1528.43|||
in|UU|1529.66|1529.9|||
this|UU|1529.9|1530.2|||
case|UU|1530.2|1530.71|.||
For|UU|1530.71|1530.98|||
one|UU|1530.98|1531.22|||
to|UU|1531.22|1531.31|||
two|UU|1531.31|1531.55|||
doses|UU|1531.55|1531.91|||
a|UU|1531.92|1532.43|||
day|UU|1532.66|1533.22|,||
one|UU|1533.23|1533.38|||
to|UU|1533.38|1533.47|||
two|UU|1533.47|1533.65|||
day|UU|1533.65|1533.83|||
dosing|UU|1533.83|1534.22|||
paradigm|UU|1534.22|1534.91|,||
you're|UU|1535.21|1535.45|||
thinking|UU|1535.45|1535.87|||
of|UU|1535.87|1536.17|||
of|UU|1536.17|1536.65|||
a|UU|1536.68|1536.92|||
limited|UU|1536.92|1537.49|||
number|UU|1537.49|1537.85|||
of|UU|1537.85|1537.97|||
doses|UU|1537.97|1538.54|||
for|UU|1538.84|1538.99|||
the|UU|1538.99|1539.11|||
twenty|UU|1539.11|1539.44|||
eight|UU|1539.44|1539.59|||
day|UU|1539.59|1539.83|||
dosing|UU|1539.83|1540.25|||
paradigm|UU|1540.25|1540.91|.||
I|UU|1540.91|1541.03|||
would|UU|1541.03|1541.18|||
expect|UU|1541.18|1541.66|||
we|UU|1541.66|1541.81|||
would|UU|1541.81|1541.99|||
dose|UU|1541.99|1542.41|||
Cuidad|UU|1543.04|1543.79|,||
which|UU|1543.79|1544.03|||
is|UU|1544.03|1544.18|||
the|UU|1544.18|1544.48|||
first|UU|1544.48|1545.02|||
phase|UU|1545.02|1545.47|||
of|UU|1545.47|1545.56|||
our|UU|1545.56|1545.65|||
induction|UU|1545.65|1546.16|||
maintenance|UU|1546.16|1546.82|||
dosing|UU|1547.66|1548.2|||
paradigm|UU|1548.2|1548.92|,||
which|UU|1548.92|1549.16|||
was|UU|1549.16|1549.31|||
established|UU|1549.31|1549.97|||
with|UU|1549.97|1550.27|||
the|UU|1550.27|1550.42|||
release|UU|1550.42|1550.9|||
of|UU|1550.9|1550.99|||
the|UU|1550.99|1551.08|||
Phase|UU|1551.08|1551.44|||
three|UU|1551.44|1551.7|||
of|UU|1551.7|1551.77|||
new|UU|1551.87|1552.04|||
trial|UU|1552.04|1552.58|||
back|UU|1553.3|1553.75|||
in|UU|1553.75|1554.26|||
December|UU|1554.98|1555.58|.||
In|UU|1556.22|1556.51|||
terms|UU|1556.51|1556.87|||
of|UU|1556.87|1556.99|||
how|UU|1556.99|1557.2|||
physicians|UU|1557.2|1557.95|||
look|UU|1558.22|1558.58|||
at|UU|1558.58|1558.79|||
the|UU|1558.79|1559.03|||
dosing|UU|1559.03|1559.51|||
paradigm|UU|1559.51|1559.93|||
for|UU|1559.93|1560.12|||
approx|UU|1560.14|1560.59|||
up|UU|1560.68|1560.86|||
in|UU|1560.86|1561.01|||
general|UU|1561.01|1561.67|||
in|UU|1562.54|1562.78|||
terms|UU|1562.78|1563.02|||
of|UU|1563.02|1563.08|||
treating|UU|1563.08|1563.47|||
patients|UU|1563.47|1564.15|,||
I|UU|1564.58|1564.79|||
think|UU|1564.79|1565.12|||
that|UU|1565.12|1565.6|||
the|UU|1566.11|1566.32|||
induction|UU|1566.32|1566.8|||
maintenance|UU|1566.8|1567.19|||
paradigm|UU|1567.19|1567.76|||
established|UU|1567.76|1568.3|||
with|UU|1568.3|1568.48|||
Renew|UU|1568.48|1569.08|||
over|UU|1569.35|1569.83|||
12|UU|1569.83|1570.22|||
weeks|UU|1570.22|1570.73|||
really|UU|1571.84|1572.32|||
sets|UU|1572.32|1572.68|||
the|UU|1572.68|1572.8|||
tone|UU|1572.8|1573.4|||
and|UU|1573.67|1574.6|||
more|UU|1574.6|1574.87|||
precisely|UU|1574.87|1575.59|||
the|UU|1575.59|1575.74|||
label|UU|1575.74|1576.28|||
for|UU|1576.28|1576.49|||
how|UU|1576.49|1576.67|||
the|UU|1576.67|1576.76|||
drug|UU|1576.76|1577.0|||
will|UU|1577.0|1577.09|||
be|UU|1577.09|1577.21|||
used|UU|1577.21|1577.51|,||
and|UU|1577.51|1577.6|||
that|UU|1577.6|1577.78|||
is|UU|1577.78|1578.08|||
acuity|UU|1578.83|1579.58|||
dosing|UU|1579.58|1580.03|||
initially|UU|1580.03|1580.72|||
followed|UU|1581.38|1581.83|||
by|UU|1581.83|1582.04|||
Biddy's|UU|1582.04|1582.58|||
dosing|UU|1582.58|1583.15|||
for|UU|1583.72|1583.93|||
the|UU|1583.93|1584.02|||
maintenance|UU|1584.02|1584.56|||
phase|UU|1584.56|1585.01|.||
OK|UU|1586.3|1586.65|,||
that's|UU|1586.66|1586.84|||
really|UU|1586.84|1586.99|||
helpful|UU|1586.99|1587.36|.||
Maybe|UU|1588.52|1588.97|||
just|UU|1588.97|1589.18|||
a|UU|1589.18|1589.24|||
clarification|UU|1589.24|1589.84|||
question|UU|1589.84|1590.38|.||
I|UU|1590.59|1591.07|||
know|UU|1591.07|1591.19|||
in|UU|1591.19|1591.25|||
the|UU|1591.25|1591.31|||
press|UU|1591.31|1591.52|||
release|UU|1591.52|1591.69|||
it|UU|1591.7|1591.79|||
says|UU|1591.79|1592.03|||
that|UU|1592.03|1592.33|||
there's|UU|1592.33|1592.69|||
going|UU|1593.26|1593.47|||
to|UU|1593.47|1593.53|||
be|UU|1593.53|1593.65|||
a|UU|1593.65|1593.71|||
dry|UU|1593.71|1594.05|||
eye|UU|1594.05|1594.34|||
in|UU|1594.37|1594.64|||
the|UU|1594.64|1594.88|||
filing|UU|1594.88|1595.48|||
by|UU|1596.74|1596.98|||
the|UU|1596.98|1597.13|||
end|UU|1597.13|1597.43|||
of|UU|1597.43|1597.61|||
next|UU|1597.61|1598.06|||
year|UU|1598.06|1598.52|.||
Is|UU|1598.87|1599.17|||
the|UU|1599.2|1599.29|||
thinking|UU|1599.8|1600.31|||
still|UU|1600.31|1600.76|||
to|UU|1600.76|1601.06|||
continue|UU|1601.06|1601.51|||
on|UU|1601.51|1601.65|||
with|UU|1601.81|1601.96|||
a|UU|1601.96|1602.02|||
concurrent|UU|1602.02|1602.47|||
filing|UU|1602.47|1602.86|?||
Just|UU|1602.86|1603.22|||
you|UU|1603.22|1603.43|||
know|UU|1603.43|1603.54|,||
I|UU|1603.58|1603.91|||
know|UU|1603.91|1604.06|||
later|UU|1604.06|1604.37|||
says|UU|1604.39|1604.59|||
that|UU|1604.6|1604.74|||
he's|UU|1604.77|1605.08|||
also|UU|1605.08|1605.26|||
going|UU|1605.26|1605.38|||
to|UU|1605.38|1605.46|||
file|UU|1605.47|1605.63|.||
Just|UU|1605.65|1605.83|||
wondering|UU|1605.83|1606.28|||
if|UU|1606.49|1606.73|||
the|UU|1606.73|1606.82|||
expectation|UU|1606.82|1607.36|||
is|UU|1607.36|1607.48|||
that|UU|1607.48|1607.75|||
you|UU|1607.78|1607.96|||
would|UU|1607.96|1608.11|||
expect|UU|1608.11|1608.47|||
them|UU|1608.47|1608.59|||
to|UU|1608.62|1608.74|||
gather|UU|1608.74|1609.16|||
still|UU|1609.16|1609.64|.||
Our|UU|1611.31|1611.55|||
current|UU|1611.55|1612.03|||
thinking|UU|1612.03|1612.57|||
is|UU|1612.57|1612.75|||
that|UU|1612.75|1612.93|||
both|UU|1612.93|1613.26|||
will|UU|1613.26|1613.38|||
be|UU|1613.38|1613.53|||
filed|UU|1613.53|1613.86|||
together|UU|1613.86|1614.4|||
pending|UU|1615.21|1615.84|||
positive|UU|1615.99|1616.5|||
clinical|UU|1616.5|1616.86|||
data|UU|1616.86|1617.1|.||
Of|UU|1617.13|1617.19|||
course|UU|1617.19|1617.61|,||
it|UU|1618.39|1618.6|||
turns|UU|1618.6|1619.02|||
out|UU|1619.02|1619.29|||
that|UU|1619.29|1619.5|||
the|UU|1619.5|1619.65|||
timelines|UU|1619.65|1620.45|||
for|UU|1620.46|1620.64|||
dry|UU|1620.64|1620.95|||
eye|UU|1620.95|1621.06|||
disease|UU|1621.06|1621.66|||
and|UU|1622.02|1622.35|||
allergic|UU|1622.35|1622.77|||
conjunctivitis|UU|1622.77|1623.67|||
continue|UU|1624.09|1624.63|||
to|UU|1624.63|1624.72|||
overlap|UU|1624.72|1625.33|||
to|UU|1626.61|1626.76|||
safety|UU|1626.76|1627.18|||
studies|UU|1627.18|1628.02|,||
the|UU|1628.02|1628.23|||
efficacy|UU|1628.23|1628.83|||
studies|UU|1628.83|1629.58|,||
the|UU|1630.03|1630.21|||
timeline|UU|1630.21|1630.93|||
for|UU|1630.93|1631.11|||
filing|UU|1631.11|1631.59|,||
the|UU|1631.59|1631.71|||
NDA|UU|1631.71|1632.07|,||
NDA|UU|1632.37|1633.05|,||
all|UU|1633.42|1633.75|||
of|UU|1633.75|1633.87|||
those|UU|1633.87|1634.17|||
seem|UU|1634.17|1634.5|||
to|UU|1634.5|1634.68|||
overlap|UU|1634.68|1635.46|||
for|UU|1636.15|1636.48|||
dry|UU|1636.48|1637.09|||
and|UU|1637.16|1637.44|||
allergic|UU|1637.44|1637.77|||
conjunctivitis|UU|1637.77|1638.45|||
at|UU|1638.64|1638.94|||
this|UU|1638.94|1639.15|||
point|UU|1639.15|1639.57|,||
which|UU|1640.59|1640.79|||
suggests|UU|1640.8|1641.34|||
that|UU|1641.34|1641.58|||
a|UU|1641.58|1641.76|||
concurrent|UU|1641.76|1642.48|||
NDA|UU|1642.48|1643.23|||
is|UU|1643.23|1643.65|||
perhaps|UU|1643.65|1644.28|||
the|UU|1644.28|1644.4|||
best|UU|1644.4|1644.79|||
regulatory|UU|1644.79|1645.33|||
strategy|UU|1645.33|1645.89|.||
But|UU|1645.9|1646.05|||
of|UU|1646.05|1646.11|||
course|UU|1646.11|1646.41|,||
we'll|UU|1646.62|1646.83|||
have|UU|1646.83|1647.01|||
to|UU|1647.01|1647.1|||
see|UU|1647.1|1647.34|||
how|UU|1647.34|1647.7|||
events|UU|1648.48|1648.93|||
play|UU|1648.93|1649.2|||
out|UU|1649.2|1649.62|||
over|UU|1650.7|1650.94|||
the|UU|1650.94|1651.03|||
latter|UU|1651.03|1651.3|||
part|UU|1651.3|1651.54|||
of|UU|1651.54|1651.6|||
this|UU|1651.6|1651.84|||
year|UU|1651.84|1652.08|||
and|UU|1652.08|1652.17|||
the|UU|1652.17|1652.29|||
early|UU|1652.29|1652.53|||
part|UU|1652.53|1652.77|||
of|UU|1652.77|1652.86|||
next|UU|1652.86|1653.1|||
year|UU|1653.1|1653.28|||
before|UU|1653.28|1653.67|||
we|UU|1653.67|1653.85|||
can|UU|1653.85|1654.06|||
guide|UU|1654.06|1654.48|||
specifically|UU|1654.87|1655.86|||
on|UU|1656.16|1656.7|||
the|UU|1656.7|1657.12|||
possibility|UU|1657.57|1658.29|||
of|UU|1658.29|1658.41|||
a|UU|1658.41|1658.47|||
concurrent|UU|1658.47|1658.98|||
NDA|UU|1658.98|1659.59|.||
We|UU|1659.91|1660.12|||
really|UU|1660.12|1660.48|||
do|UU|1660.48|1660.75|||
like|UU|1660.75|1661.05|||
the|UU|1661.05|1661.17|||
concurrent|UU|1661.17|1661.71|||
NDA|UU|1661.71|1662.19|||
paradigm|UU|1662.19|1662.76|.||
However|UU|1662.76|1663.3|,||
because|UU|1663.54|1664.08|||
of|UU|1664.08|1664.2|||
the|UU|1664.2|1664.32|||
overlap|UU|1664.32|1665.13|||
between|UU|1665.13|1665.61|||
dry|UU|1665.61|1666.01|||
eye|UU|1666.01|1666.15|||
disease|UU|1666.15|1666.81|||
and|UU|1666.81|1666.99|||
allergic|UU|1666.99|1667.41|||
conjunctivitis|UU|1667.41|1668.28|,||
there|UU|1668.79|1668.94|||
seems|UU|1668.96|1669.36|||
to|UU|1669.36|1669.48|||
be|UU|1669.48|1669.66|||
about|UU|1669.66|1669.9|||
a|UU|1669.9|1669.96|||
50|UU|1669.96|1670.29|||
percent|UU|1670.29|1670.65|||
overlap|UU|1670.65|1671.16|||
such|UU|1671.16|1671.49|||
that|UU|1671.49|1671.73|||
about|UU|1671.94|1672.39|||
half|UU|1672.39|1672.66|||
of|UU|1672.66|1672.72|||
the|UU|1672.72|1672.81|||
patients|UU|1672.81|1673.38|||
with|UU|1673.38|1673.68|||
dry|UU|1673.68|1673.95|||
disease|UU|1673.95|1674.37|||
complain|UU|1674.37|1674.76|||
of|UU|1674.76|1674.85|||
ocular|UU|1674.85|1675.24|||
itching|UU|1675.24|1675.69|||
and|UU|1675.69|1675.78|||
about|UU|1675.78|1676.02|||
half|UU|1676.02|1676.26|||
the|UU|1676.26|1676.35|||
patients|UU|1676.35|1676.83|||
with|UU|1676.83|1676.95|||
allergic|UU|1676.95|1677.28|||
conjunctivitis|UU|1677.28|1678.03|||
complain|UU|1678.03|1678.42|||
of|UU|1678.42|1678.54|||
dryness|UU|1678.54|1679.11|.||
And|UU|1679.56|1680.16|||
a|UU|1680.16|1680.34|||
single|UU|1680.34|1680.91|||
compound|UU|1680.91|1681.6|||
that|UU|1681.93|1682.14|||
could|UU|1682.14|1682.26|||
treat|UU|1682.26|1682.62|||
both|UU|1682.62|1682.92|||
diseases|UU|1682.92|1683.43|||
or|UU|1683.43|1683.61|||
as|UU|1683.61|1683.76|||
indicated|UU|1683.76|1684.51|||
for|UU|1684.9|1685.2|||
both|UU|1685.2|1685.53|||
diseases|UU|1685.53|1686.28|,||
would|UU|1686.28|1686.55|||
be|UU|1686.55|1686.91|||
highly|UU|1686.91|1687.27|||
advantageous|UU|1687.27|1688.02|||
not|UU|1688.02|1688.2|||
only|UU|1688.2|1688.35|||
to|UU|1688.59|1689.07|||
physicians|UU|1689.25|1689.91|||
but|UU|1689.91|1690.09|||
also|UU|1690.09|1690.36|||
to|UU|1690.36|1690.45|||
patients|UU|1690.45|1690.96|||
as|UU|1690.96|1691.11|||
well|UU|1691.11|1691.36|.||
Right|UU|1692.81|1693.1|.||
I|UU|1693.3|1693.36|||
think|UU|1693.37|1693.54|||
my|UU|1694.59|1694.75|||
last|UU|1694.8|1694.92|||
question|UU|1694.98|1695.22|||
just|UU|1695.3|1695.52|||
on|UU|1696.54|1696.84|||
the|UU|1696.84|1696.93|||
safety|UU|1696.93|1697.38|||
study|UU|1697.38|1697.88|,||
is|UU|1698.1|1698.4|||
there|UU|1698.4|1698.49|||
an|UU|1698.49|1698.58|||
expectation|UU|1698.58|1699.12|||
for|UU|1699.12|1699.3|||
what|UU|1699.3|1699.48|||
the|UU|1699.48|1699.57|||
size|UU|1699.57|1699.96|||
and|UU|1699.96|1700.08|||
scope|UU|1700.08|1700.53|||
duration|UU|1701.67|1702.21|||
of|UU|1702.21|1702.33|||
the|UU|1702.34|1702.42|||
number|UU|1702.51|1702.72|||
of|UU|1702.72|1702.78|||
patients|UU|1702.78|1703.26|||
you|UU|1703.26|1703.41|||
would|UU|1703.65|1703.8|||
anticipate|UU|1703.8|1704.34|||
for|UU|1704.34|1704.71|.||
Right|UU|1706.98|1707.31|,||
for|UU|1707.31|1707.45|||
dry|UU|1707.46|1707.81|||
eye|UU|1707.81|1707.88|||
disease|UU|1707.88|1708.62|?||
My|UU|1709.83|1710.1|||
current|UU|1710.1|1710.49|||
understanding|UU|1710.49|1711.3|||
is|UU|1711.3|1711.51|||
that|UU|1711.51|1712.02|||
the|UU|1712.05|1712.26|||
FDA|UU|1712.26|1712.83|||
generally|UU|1712.83|1713.64|||
requires|UU|1713.64|1714.54|||
one|UU|1714.96|1715.38|||
hundred|UU|1715.38|1715.71|||
patients|UU|1715.71|1716.34|||
complete|UU|1716.34|1716.91|||
one|UU|1717.06|1717.48|||
year|UU|1717.48|1717.93|||
of|UU|1717.93|1718.23|||
dosing|UU|1718.23|1718.68|.||
However|UU|1720.06|1720.69|,||
based|UU|1722.55|1723.03|||
on|UU|1723.03|1723.51|||
other|UU|1724.65|1725.01|||
other|UU|1725.28|1725.7|||
sponsors|UU|1725.82|1726.48|||
interactions|UU|1726.48|1727.11|||
with|UU|1727.11|1727.26|||
the|UU|1727.26|1727.38|||
agency|UU|1727.38|1727.98|,||
we|UU|1727.98|1728.16|||
believe|UU|1728.16|1728.7|||
that|UU|1728.7|1728.85|||
we|UU|1728.85|1729.03|||
can|UU|1729.03|1729.24|||
file|UU|1729.24|1729.87|||
based|UU|1729.87|1730.23|||
on|UU|1730.23|1730.38|||
six|UU|1730.38|1730.92|||
months|UU|1730.92|1731.34|||
of|UU|1732.0|1732.3|||
safety|UU|1732.3|1732.75|||
data|UU|1732.75|1733.11|.||
So|UU|1733.89|1734.22|||
what|UU|1734.22|1734.43|||
happens|UU|1734.43|1734.85|||
is|UU|1734.85|1735.0|||
most|UU|1735.0|1735.27|||
sponsors|UU|1735.27|1735.81|||
will|UU|1735.81|1736.02|||
overenrolled|UU|1736.02|1737.07|.||
They'll|UU|1737.07|1737.22|||
begin|UU|1737.22|1737.73|||
with|UU|1737.73|1737.97|||
more|UU|1737.97|1738.21|||
than|UU|1738.21|1738.36|||
a|UU|1738.36|1738.42|||
hundred|UU|1738.42|1738.72|||
patients|UU|1738.72|1739.32|||
such|UU|1739.92|1740.28|||
that|UU|1740.28|1740.7|||
they|UU|1740.94|1741.15|||
have|UU|1741.15|1741.33|||
one|UU|1741.33|1741.42|||
hundred|UU|1741.42|1741.96|||
completers|UU|1741.96|1742.83|||
at|UU|1742.89|1743.43|||
at|UU|1743.82|1744.06|||
12|UU|1744.06|1744.45|||
months|UU|1744.45|1744.79|.||
And|UU|1745.65|1745.98|||
to|UU|1745.98|1746.22|||
our|UU|1746.22|1746.4|||
knowledge|UU|1746.4|1747.03|,||
the|UU|1747.03|1747.69|||
safety|UU|1748.62|1749.04|||
trials|UU|1749.04|1749.73|||
are|UU|1750.18|1750.71|||
are|UU|1751.35|1751.65|||
fairly|UU|1751.68|1752.13|||
standard|UU|1752.13|1752.79|||
and|UU|1752.97|1753.6|||
dry|UU|1753.6|1753.91|||
eye|UU|1753.91|1754.05|||
disease|UU|1754.05|1754.63|.||
I|UU|1755.61|1755.79|||
will|UU|1755.79|1756.06|||
say|UU|1756.06|1756.39|,||
as|UU|1756.39|1756.51|||
I|UU|1756.51|1756.57|||
mentioned|UU|1756.57|1756.96|||
in|UU|1756.96|1757.08|||
my|UU|1757.08|1757.47|||
prepared|UU|1758.07|1758.55|||
comments|UU|1758.55|1759.17|,||
that|UU|1759.3|1759.57|||
we've|UU|1759.57|1759.81|||
tested|UU|1759.81|1760.38|||
well|UU|1761.55|1761.94|||
over|UU|1761.94|1762.21|||
a|UU|1762.21|1762.27|||
thousand|UU|1762.27|1762.81|||
patients|UU|1762.81|1763.5|.||
We|UU|1764.25|1764.46|||
have|UU|1764.46|1764.61|||
seen|UU|1764.61|1765.12|||
no|UU|1765.42|1765.9|||
safety|UU|1765.9|1766.35|||
signals|UU|1766.35|1766.89|,||
no|UU|1767.46|1767.79|||
changes|UU|1767.79|1768.21|||
in|UU|1768.21|1768.3|||
intraocular|UU|1768.3|1768.93|||
pressure|UU|1768.93|1769.53|,||
no|UU|1770.22|1770.49|||
retinal|UU|1770.49|1770.97|||
findings|UU|1770.97|1771.72|,||
no|UU|1772.5|1773.04|||
aberrant|UU|1773.04|1773.61|||
coronial|UU|1773.61|1774.15|||
findings|UU|1774.15|1774.75|||
or|UU|1775.59|1775.83|||
any|UU|1775.83|1776.04|||
other|UU|1776.04|1776.28|||
safety|UU|1776.28|1776.94|||
signals|UU|1777.84|1778.41|||
that|UU|1778.41|1778.56|||
would|UU|1778.56|1778.68|||
suggest|UU|1778.68|1779.22|||
that|UU|1779.22|1779.4|||
there|UU|1779.4|1779.79|||
has|UU|1780.09|1780.36|||
been|UU|1780.36|1780.54|||
an|UU|1780.54|1780.66|||
issue|UU|1780.66|1780.99|||
with|UU|1780.99|1781.32|||
reproachful|UU|1781.48|1781.98|||
dosing|UU|1782.13|1782.52|||
and|UU|1782.52|1782.67|||
any|UU|1782.67|1782.88|||
patient|UU|1782.88|1783.39|||
that's|UU|1783.39|1783.63|||
received|UU|1783.63|1784.02|||
drugs|UU|1784.02|1784.34|||
so|UU|1784.77|1785.04|||
far|UU|1785.04|1785.37|.||
Great|UU|1786.84|1787.14|.||
Thanks|UU|1787.56|1787.86|||
again|UU|1787.86|1788.09|.||
And|UU|1788.1|1788.22|||
I|UU|1788.22|1788.3|||
hope|UU|1788.31|1788.54|||
I|UU|1788.55|1788.61|||
can|UU|1788.61|1788.79|||
keep|UU|1788.79|1789.06|||
the|UU|1789.45|1789.74|||
safe|UU|1789.82|1790.05|||
just|UU|1790.08|1790.33|.||
And|UU|1792.55|1792.82|||
there|UU|1792.82|1792.97|||
are|UU|1792.97|1793.03|||
no|UU|1793.03|1793.21|||
further|UU|1793.21|1793.48|||
questions|UU|1793.48|1793.96|||
at|UU|1793.96|1794.05|||
this|UU|1794.05|1794.26|||
time|UU|1794.26|1794.52|.||
We'll|UU|1794.56|1794.71|||
turn|UU|1794.71|1794.89|||
the|UU|1794.89|1794.98|||
call|UU|1794.98|1795.22|||
back|UU|1795.22|1795.46|||
over|UU|1795.46|1795.7|||
to|UU|1795.7|1795.82|||
Dr.|UU|1795.82|1796.15|||
Brady|UU|1796.15|1796.51|||
for|UU|1796.51|1796.63|||
closing|UU|1796.63|1796.99|||
remarks|UU|1796.99|1797.49|.||
Well|UU|1800.84|1800.99|,||
thank|UU|1800.99|1801.2|||
you|UU|1801.2|1801.32|||
all|UU|1801.32|1801.47|||
again|UU|1801.47|1801.71|||
for|UU|1801.71|1801.83|||
joining|UU|1801.83|1802.16|||
us|UU|1802.16|1802.31|||
today|UU|1802.31|1802.88|.||
As|UU|1803.21|1803.6|||
always|UU|1803.6|1804.32|,||
we|UU|1804.68|1804.89|||
look|UU|1804.89|1805.04|||
forward|UU|1805.04|1805.37|||
to|UU|1805.37|1805.52|||
keeping|UU|1805.52|1805.91|||
you|UU|1805.91|1806.06|||
updated|UU|1806.06|1806.48|||
on|UU|1806.48|1806.6|||
our|UU|1806.6|1806.72|||
progress|UU|1806.72|1807.44|.||
Have|UU|1808.13|1808.4|||
a|UU|1808.4|1808.43|||
nice|UU|1808.43|1808.64|||
day|UU|1808.64|1808.87|.||
Thank|UU|1808.91|1809.15|||
you|UU|1809.15|1809.36|.||
Thank|UU|1810.89|1811.16|||
you|UU|1811.16|1811.22|.||
Ladies|UU|1811.23|1811.52|||
and|UU|1811.52|1811.64|||
gentlemen|UU|1811.64|1812.06|,||
that|UU|1812.06|1812.21|||
does|UU|1812.21|1812.39|||
conclude|UU|1812.39|1812.72|||
today's|UU|1812.72|1813.2|||
conference|UU|1813.2|1813.59|||
call|UU|1813.59|1813.8|.||
We|UU|1813.83|1813.92|||
thank|UU|1813.92|1814.07|||
you|UU|1814.07|1814.16|||
for|UU|1814.16|1814.34|||
your|UU|1814.34|1814.49|||
participation|UU|1814.49|1815.21|||
and|UU|1815.21|1815.3|||
ask|UU|1815.3|1815.48|||
that|UU|1815.48|1815.6|||
you|UU|1815.6|1815.69|||
please|UU|1815.69|1815.96|||
disconnect|UU|1815.96|1816.47|||
your|UU|1816.47|1816.62|||
lines|UU|1816.62|1817.0|.||
